Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	protein-DNA complex organization	BDP1 SATB2 BCORL1 FAM47C REST NCOR1 TAF3 KMT2D PBRM1 RESF1 BRDT SUPT6H CENPI MED25 PAK1 KMT2A SMARCD2 CABIN1 SPOCD1 INO80B	2.11e-05	999	144	20	GO:0071824
GeneOntologyBiologicalProcess	neuron development	ROR2 DAB2 LAMA5 NBL1 REST INPP5F GFRA3 AREG ASAP1 SLC12A5 PRDM1 PBRM1 GLI3 SIPA1L1 UNC5C ITSN2 PAK1 UNK MACF1 ROM1 KEL GOLGA8A EPHA10 ARHGAP33 MOV10	2.65e-05	1463	144	25	GO:0048666
GeneOntologyCellularComponent	coated vesicle membrane	COPA SEC24A ROR2 DAB2 APOB SEC31B AREG USO1	1.37e-04	215	146	8	GO:0030662
GeneOntologyCellularComponent	coated vesicle	COPA SEC24A ROR2 DAB2 APOB INPP5F SEC31B AREG USO1 GOLGA8A	2.26e-04	360	146	10	GO:0030135
GeneOntologyCellularComponent	nuclear protein-containing complex	TRERF1 SATB2 SPAG4 CTC1 MIDEAS STAT2 STAT4 NCOR1 TAF3 KMT2D PBRM1 PRPF3 SUPT6H SYNE2 MED25 KMT2A AFF1 SMARCD2 DDX20 MGA MED12 INO80B	2.28e-04	1377	146	22	GO:0140513
GeneOntologyCellularComponent	transcription regulator complex	TRERF1 BDP1 SATB2 REST MIDEAS STAT2 STAT4 NCOR1 TAF3 GLI3 MED25 DDX20 MGA	2.87e-04	596	146	13	GO:0005667
Domain	BAT2_N	PRRC2C PRRC2A PRRC2B	4.58e-07	3	145	3	PF07001
Domain	BAT2_N	PRRC2C PRRC2A PRRC2B	4.58e-07	3	145	3	IPR009738
Domain	PRRC2	PRRC2C PRRC2A PRRC2B	4.58e-07	3	145	3	IPR033184
Domain	PRR14	PRR14 PRR14L	5.99e-05	2	145	2	IPR026320
Domain	Tantalus-like	PRR14 PRR14L	5.99e-05	2	145	2	IPR028149
Domain	Tantalus	PRR14 PRR14L	5.99e-05	2	145	2	PF15386
Domain	SH2	SH3BP2 LCP2 STAT2 STAT4 CISH SUPT6H	1.37e-04	101	145	6	PF00017
Domain	BTP	TAF3 SUPT7L	1.79e-04	3	145	2	SM00576
Domain	BTP	TAF3 SUPT7L	1.79e-04	3	145	2	IPR006565
Domain	Bromo_TP	TAF3 SUPT7L	1.79e-04	3	145	2	PF07524
Domain	MYB_LIKE	TRERF1 BDP1 MIDEAS NCOR1	2.10e-04	38	145	4	PS50090
Domain	SH2	SH3BP2 LCP2 STAT2 STAT4 CISH SUPT6H	2.18e-04	110	145	6	SM00252
Domain	SH2	SH3BP2 LCP2 STAT2 STAT4 CISH SUPT6H	2.29e-04	111	145	6	PS50001
Domain	SH2	SH3BP2 LCP2 STAT2 STAT4 CISH SUPT6H	2.40e-04	112	145	6	IPR000980
Domain	-	SH3BP2 LCP2 STAT2 STAT4 CISH SUPT6H	2.40e-04	112	145	6	3.30.505.10
Domain	KCL_cotranspt	SLC12A6 SLC12A5	3.56e-04	4	145	2	IPR000076
Domain	FYrich_C	KMT2D KMT2A	5.89e-04	5	145	2	IPR003889
Domain	FYrich_N	KMT2D KMT2A	5.89e-04	5	145	2	IPR003888
Domain	FYRC	KMT2D KMT2A	5.89e-04	5	145	2	SM00542
Domain	FYRN	KMT2D KMT2A	5.89e-04	5	145	2	SM00541
Domain	FYRN	KMT2D KMT2A	5.89e-04	5	145	2	PF05964
Domain	FYRC	KMT2D KMT2A	5.89e-04	5	145	2	PF05965
Domain	FYRC	KMT2D KMT2A	5.89e-04	5	145	2	PS51543
Domain	FYRN	KMT2D KMT2A	5.89e-04	5	145	2	PS51542
Domain	SANT	TRERF1 BDP1 MIDEAS NCOR1	6.08e-04	50	145	4	SM00717
Domain	EPHD	KMT2D KMT2A RAI1	6.33e-04	22	145	3	PS51805
Domain	SANT/Myb	TRERF1 BDP1 MIDEAS NCOR1	7.07e-04	52	145	4	IPR001005
Domain	MA3	EIF4G1 EIF4G3	8.80e-04	6	145	2	SM00544
Domain	MA3	EIF4G1 EIF4G3	8.80e-04	6	145	2	PF02847
Domain	Initiation_fac_eIF4g_MI	EIF4G1 EIF4G3	8.80e-04	6	145	2	IPR003891
Domain	Haem_d1	COPA KMT2A	8.80e-04	6	145	2	IPR011048
Domain	MI	EIF4G1 EIF4G3	8.80e-04	6	145	2	PS51366
Domain	SANT_dom	TRERF1 MIDEAS NCOR1	1.05e-03	26	145	3	IPR017884
Domain	STAT_TF_DNA-bd_sub	STAT2 STAT4	1.23e-03	7	145	2	IPR012345
Domain	STAT	STAT2 STAT4	1.23e-03	7	145	2	IPR001217
Domain	eIF5C	EIF4G1 EIF4G3	1.23e-03	7	145	2	SM00515
Domain	STAT_int	STAT2 STAT4	1.23e-03	7	145	2	SM00964
Domain	STAT_TF_DNA-bd	STAT2 STAT4	1.23e-03	7	145	2	IPR013801
Domain	STAT_bind	STAT2 STAT4	1.23e-03	7	145	2	PF02864
Domain	STAT_int	STAT2 STAT4	1.23e-03	7	145	2	PF02865
Domain	-	STAT2 STAT4	1.23e-03	7	145	2	1.10.532.10
Domain	STAT_alpha	STAT2 STAT4	1.23e-03	7	145	2	PF01017
Domain	-	STAT2 STAT4	1.23e-03	7	145	2	1.20.1050.20
Domain	SLC12A_fam	SLC12A6 SLC12A5	1.23e-03	7	145	2	IPR004842
Domain	STAT_TF_prot_interaction	STAT2 STAT4	1.23e-03	7	145	2	IPR013799
Domain	STAT_TF_coiled-coil	STAT2 STAT4	1.23e-03	7	145	2	IPR015988
Domain	-	STAT2 STAT4	1.23e-03	7	145	2	2.60.40.630
Domain	W2	EIF4G1 EIF4G3	1.23e-03	7	145	2	PF02020
Domain	W2	EIF4G1 EIF4G3	1.23e-03	7	145	2	PS51363
Domain	W2_domain	EIF4G1 EIF4G3	1.23e-03	7	145	2	IPR003307
Domain	SANT	TRERF1 MIDEAS NCOR1	1.30e-03	28	145	3	PS51293
Domain	STAT_TF_alpha	STAT2 STAT4	1.63e-03	8	145	2	IPR013800
Domain	SLC12_C	SLC12A6 SLC12A5	1.63e-03	8	145	2	IPR018491
Domain	SLC12	SLC12A6 SLC12A5	1.63e-03	8	145	2	PF03522
Domain	Myb_DNA-binding	TRERF1 MIDEAS NCOR1	2.50e-03	35	145	3	PF00249
Domain	MIF4G	EIF4G1 EIF4G3	2.59e-03	10	145	2	SM00543
Domain	MIF4G	EIF4G1 EIF4G3	2.59e-03	10	145	2	PF02854
Domain	MIF4G-like_typ-3	EIF4G1 EIF4G3	2.59e-03	10	145	2	IPR003890
Domain	SET	PRDM1 KMT2D KMT2A	3.94e-03	41	145	3	PF00856
Domain	BROMODOMAIN_2	PBRM1 BRDT KMT2A	3.94e-03	41	145	3	PS50014
Domain	Bromodomain	PBRM1 BRDT KMT2A	4.22e-03	42	145	3	IPR001487
Domain	BROMO	PBRM1 BRDT KMT2A	4.22e-03	42	145	3	SM00297
Domain	-	PBRM1 BRDT KMT2A	4.22e-03	42	145	3	1.20.920.10
Domain	ELM2_dom	TRERF1 MIDEAS	4.41e-03	13	145	2	IPR000949
Domain	ELM2	TRERF1 MIDEAS	4.41e-03	13	145	2	PF01448
Domain	ELM2	TRERF1 MIDEAS	4.41e-03	13	145	2	PS51156
Domain	ELM2	TRERF1 MIDEAS	4.41e-03	13	145	2	SM01189
Domain	PHD	TAF3 KMT2D KMT2A RAI1	5.11e-03	89	145	4	SM00249
Domain	NPIP	NPIPB15 NPIPB9	5.12e-03	14	145	2	IPR009443
Domain	SET	PRDM1 KMT2D KMT2A	5.45e-03	46	145	3	SM00317
Domain	Znf_PHD	TAF3 KMT2D KMT2A RAI1	5.53e-03	91	145	4	IPR001965
Domain	-	EIF4G1 EIF4G3	5.88e-03	15	145	2	1.25.40.180
Domain	MIF4-like	EIF4G1 EIF4G3	5.88e-03	15	145	2	IPR016021
Domain	ZF_PHD_2	TAF3 KMT2D KMT2A RAI1	6.43e-03	95	145	4	PS50016
Domain	ZF_PHD_1	TAF3 KMT2D KMT2A RAI1	6.67e-03	96	145	4	PS01359
Domain	Post-SET_dom	KMT2D KMT2A	6.69e-03	16	145	2	IPR003616
Domain	PostSET	KMT2D KMT2A	6.69e-03	16	145	2	SM00508
Domain	Laminin_N	LAMA5 USH2A	6.69e-03	16	145	2	IPR008211
Domain	LamNT	LAMA5 USH2A	6.69e-03	16	145	2	SM00136
Domain	LAMININ_NTER	LAMA5 USH2A	6.69e-03	16	145	2	PS51117
Domain	Laminin_N	LAMA5 USH2A	6.69e-03	16	145	2	PF00055
Domain	POST_SET	KMT2D KMT2A	6.69e-03	16	145	2	PS50868
Domain	SET_dom	PRDM1 KMT2D KMT2A	6.88e-03	50	145	3	IPR001214
Domain	SET	PRDM1 KMT2D KMT2A	6.88e-03	50	145	3	PS50280
Pubmed	Human transcription factor protein interaction networks.	TRERF1 KLF8 SATB2 COPA SEC24A BCORL1 MIDEAS CIC STAT2 STAT4 PRDM1 NCOR1 TAF3 KMT2D PBRM1 RESF1 MRPL15 PRRC2C MRPS25 FUBP1 GLI3 SLC25A13 ZNF746 SYNE2 SUPT7L EIF4G1 MARF1 KMT2A ANKRD17 UNK SMARCD2 EIF3H CABIN1 MGA ATP2A2 PRRC2A INO80B PRRC2B MOV10 FOXI1	8.81e-22	1429	149	40	35140242
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TRERF1 U2SURP ZNF362 MIDEAS CIC NCOR1 KMT2D PBRM1 PRPF3 SUPT7L KMT2A SMARCD2 MGA MED12 PRRC2B RAI1	4.84e-14	268	149	16	33640491
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SLC12A6 LARP6 COPA COL20A1 PPRC1 U2SURP CC2D1B APOB STOX1 NCAPH CCDC57 NCOR1 PRRC2C MRPS25 FUBP1 EFCAB12 SLC25A13 SYNE2 UNC5C ITSN2 EIF4G1 MARF1 KMT2A MACF1 SMARCD2 EIF4G3 CCDC89 ATP2A2 DNAH8 PRRC2B RAI1	8.96e-14	1442	149	31	35575683
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 COPA U2SURP PRKRA PBRM1 SUPT6H PRRC2C SLC25A13 SYNE2 EIF4G1 KMT2A ANKRD17 MACF1 DDX20 EIF4G3 ATP2A2 PRRC2A MED12 PRRC2B MOV10 RAI1	8.33e-13	653	149	21	22586326
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	LARP6 CTC1 MYO9B PRKRA USP10 PRRC2C FUBP1 EIF4G1 ANKRD17 UNK DDX20 EIF3H EIF4G3 PRRC2A MED12 WNK2 PRRC2B MOV10	1.70e-12	462	149	18	31138677
Pubmed	Interaction network of human early embryonic transcription factors.	TRERF1 SATB2 BCORL1 MIDEAS NCOR1 TAF3 KMT2D PBRM1 RESF1 ZNF746 KMT2A SMARCD2 MGA MED12 PRRC2B RAI1	2.99e-12	351	149	16	38297188
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TRERF1 COPA DAB2 IQCN REST CIC NCOR1 USP10 TAF3 KMT2D RPAP1 FUBP1 SIPA1L1 EIF4G1 KMT2A ANKRD17 UNK AFF1 DDX20 ATP2A2 PRRC2A	2.02e-11	774	149	21	15302935
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	LAMA5 ZNF385A CIC USP10 PBRM1 SUPT6H SIPA1L1 SLC25A13 SUPT7L ITSN2 EIF4G1 MED25 CIZ1 KMT2A ANKRD17 UNK MACF1 DDX20 EIF3H EIF4G3 ATP2A2 PRRC2A FHIP1A MED12 INO80B MAN1B1 MOV10 ATP6V0A2	4.43e-11	1497	149	28	31527615
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	TRERF1 KLF8 SATB2 RHOBTB3 ZNF385A REST CIC STAT2 STAT4 PRDM1 NCOR1 PRR14 PBRM1 BRDT ZIC5 GLI3 CIZ1 UNK SMARCD2 EIF3H MGA	4.47e-11	808	149	21	20412781
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 RHOBTB3 SH3BP2 ADNP2 ZNF362 TAF3 PBRM1 RESF1 BRDT PRPF3 GLI3 SIPA1L1 SLC25A13 SUPT7L CIZ1 ANKRD17 MACF1 SMARCD2 MGA INO80B ARHGAP33 PRRC2B RAI1	4.70e-10	1116	149	23	31753913
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TRERF1 DAB2 CIC ASAP1 NCOR1 PRR14 TULP4 PAK1 UNK AFF1 EIF4G3 MGA FHIP1A WNK2 FOXI1	6.12e-10	430	149	15	35044719
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BDP1 USP34 MYO9B BCORL1 TACC2 CIC STAT2 NCOR1 RESF1 USO1 SUPT6H PRRC2C MED25 UNK MACF1 DDX20 PRRC2B	7.31e-10	588	149	17	38580884
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	COPA PRKRA USP10 SH3PXD2B PRRC2C EIF4G1 MARF1 ANKRD17 UNK MACF1 SMARCD2 EIF3H EIF4G3 MGA ATP2A2 PRRC2A PRRC2B MOV10	2.42e-09	724	149	18	36232890
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	SATB2 MIDEAS KMT2D PBRM1 RESF1 MED25 SMARCD2 CABIN1 MGA MED12	3.06e-09	167	149	10	20362541
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TRERF1 SLC12A5 NCOR1 USP10 SH3PXD2B PBRM1 PRRC2C SIPA1L1 SYNE2 EIF4G1 PAK1 ANKRD17 MACF1 CABIN1 MGA GOLGA8A PRRC2A WNK2 PRRC2B RAI1	6.27e-09	963	149	20	28671696
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 CTC1 MYO9B PPRC1 SHISA5 LAMA5 NBL1 CIC NCOR1 SH3PXD2B KMT2D RPAP1 TULP4 EIF4G1 CABIN1 DOCK6 MED12 WNK2 ARHGAP33 PRRC2B RAI1	1.18e-08	1105	149	21	35748872
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCAPH MIDEAS NCOR1 USP10 SH3PXD2B TAF3 KMT2D PRRC2C SLC25A13 CIZ1 KMT2A MGA PRRC2A MED12 PRRC2B	1.64e-08	549	149	15	38280479
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	COPA NDUFB6 PRKRA NCOR1 USP10 PBRM1 SUPT6H PRRC2C SIPA1L1 UNK SMARCD2 DDX20 PRRC2A PRRC2B	1.97e-08	475	149	14	31040226
Pubmed	A human MAP kinase interactome.	DAB2 ADNP2 LCP2 MIDEAS CIC ASAP1 MAP3K4 ITSN2 PAK1 ANKRD17 MACF1 MGA WNK2 ARHGAP33	2.62e-08	486	149	14	20936779
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	U2SURP BCORL1 ZNF362 MIDEAS CIC NCOR1 TAF3 PRPF3 PRRC2C FUBP1 EIF4G1 CIZ1 MARF1 KMT2A MGA ATP2A2 PRRC2A INO80B RAI1	3.01e-08	954	149	19	36373674
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TRERF1 USP34 SATB2 BCORL1 INPP5F CIC NCOR1 KMT2D RESF1 USO1 ANKRD17 MGA MED12	3.46e-08	418	149	13	34709266
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	COPA DAB2 TACC2 NCAPH NCOR1 USP10 PBRM1 FUBP1 EIF4G1 PAK1 SMARCD2 DDX20 EIF4G3 PRRC2A	4.01e-08	503	149	14	16964243
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	USP34 U2SURP MIDEAS NCOR1 KMT2D PBRM1 PRPF3 FUBP1 SMARCD2 MED12	4.24e-08	220	149	10	35785414
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	USP34 COPA DAB2 NCAPH HPSE PRKRA USP10 MRPL15 PRPF3 PRRC2C MRPS25 SIPA1L1 SLC25A13 SYNE2 EIF4G1 KMT2A DDX20 EIF3H CABIN1 ATP2A2 PRRC2A PRRC2B MOV10	5.47e-08	1440	149	23	30833792
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRERF1 SATB2 U2SURP BCORL1 ZNF362 MIDEAS CIC NCOR1 KMT2D RESF1 PRPF3 PRRC2C FUBP1 KMT2A SMARCD2 ATP2A2 PRRC2A MED12 PRRC2B RAI1	5.86e-08	1103	149	20	34189442
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	USP34 CTC1 MIDEAS FUBP1 SLC25A13 CENPI MED25 SMARCD2 DDX20 CABIN1 MGA ATP2A2 MED12	8.80e-08	453	149	13	29656893
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	USP34 SEC24A MIDEAS CIC NCOR1 PRR14 KMT2D PRRC2C FUBP1 FAM222B ANKRD17 PRRC2B RAI1	9.74e-08	457	149	13	32344865
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	BCORL1 CIC PRRC2C ANKRD17 DDX20 EIF4G3 PRRC2A MED12 PRRC2B MOV10	1.04e-07	242	149	10	34011540
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	SATB2 BCORL1 SEC31B CIC NCOR1 KMT2D PBRM1 MRPS25 SYNE2 SUPT7L UNC5C ITSN2 ANKRD17 PRRC2B RAI1	1.16e-07	638	149	15	31182584
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	COPA MYO9B TACC2 PRKRA USP10 PBRM1 PRPF3 PRRC2C SLC25A13 EIF4G1 MACF1 EIF3H EIF4G3 PRRC2A MED12 MOV10	1.88e-07	759	149	16	35915203
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	CTC1 MYO9B U2SURP USP10 SH3PXD2B PBRM1 PRPF3 PRRC2C SLC25A13 EIF4G1 DDX20 PRRC2A MOV10	1.97e-07	486	149	13	30940648
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	COPA MYO9B U2SURP ADNP2 VTA1 NCAPH MIDEAS ASAP1 PRKRA PRPF3 FUBP1 SLC25A13 EIF4G1 ANKRD17 MACF1 DDX20 PRR14L MGA ATP2A2 MED12 MOV10	3.53e-07	1353	149	21	29467282
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SLC12A6 BDP1 KLF8 SH3BP2 ROR2 ZNF362 IQCN ZNF385A CCDC57 USP10 TULP4 PRPF3 SUPT6H FUBP1 ANKRD17 AFF1 MACF1 EIF4G3 DOCK6 WNK2 MAN1B1 RAI1	4.15e-07	1489	149	22	28611215
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	SH3BP2 DAB2 MIDEAS ASAP1 SH3PXD2B CIZ1 PRRC2A	4.46e-07	108	149	7	19531213
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	U2SURP MIDEAS PRKRA USP10 TULP4 SUPT6H PRRC2C EIF4G1 ANKRD17 SMARCD2 EIF3H PRRC2A PRRC2B MOV10	4.60e-07	615	149	14	31048545
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 SATB2 RHOBTB3 LAMA5 INPP5F NCAPH USP10 SUPT6H ANKRD17 UNK DOCK6 WNK2 RAI1	5.13e-07	529	149	13	14621295
Pubmed	Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.	U2SURP USP10 PRPF3 PRRC2C EIF4G1 EIF3H EIF4G3 PRRC2A MOV10	5.59e-07	223	149	9	20020773
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	TRERF1 U2SURP MIDEAS ASAP1 PRKRA USP10 PRRC2C MRPS25 SLC25A13 ANKRD17 ATP2A2 PRRC2A PRRC2B MOV10	9.69e-07	655	149	14	35819319
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SEC24A ROR2 INPP5F CIC SH3PXD2B RESF1 USO1 PRRC2C SIPA1L1 SYNE2 EIF4G1 KMT2A ANKRD17 MACF1 EIF4G3 DOCK6	9.91e-07	861	149	16	36931259
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	SATB2 ADNP2 ZNF362 RESF1 ZNF746 SUPT7L MGA	1.20e-06	125	149	7	32891193
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	TRERF1 USP34 SATB2 COPA BCORL1 PBRM1 RESF1 BRDT ZIC5 PRPF3 DDX20	1.23e-06	396	149	11	26687479
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	SATB2 BCORL1 ADNP2 KMT2D PBRM1 RESF1 SYNE2 CIZ1 SMARCD2 DDX20 MGA	1.29e-06	398	149	11	35016035
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	KMT2D PRPF3 MRPS25 FUBP1 SIPA1L1 SMARCD2 EIF3H MGA ATP2A2 MED12 MOV10	1.72e-06	410	149	11	26949251
Pubmed	Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.	COPA U2SURP USP10 MRPL15 MRPS25 SLC25A13 DDX20 ATP2A2 PRRC2A MOV10	1.91e-06	333	149	10	36779763
Pubmed	A census of human transcription factors: function, expression and evolution.	TRERF1 KLF8 SATB2 ADNP2 ZNF385A REST MIDEAS CIC STAT2 STAT4 PRDM1 KMT2D GLI3 KMT2A MGA FOXI1	1.97e-06	908	149	16	19274049
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	U2SURP ZNF385A PRKRA USP10 MRPL15 PRPF3 SUPT6H PRRC2C FUBP1 UNK MACF1 EIF4G3 PRRC2A PRRC2B MOV10	2.20e-06	807	149	15	22681889
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	COPA U2SURP VTA1 NCAPH PRKRA USO1 PRRC2C MRPS25 FUBP1 EIF4G1 ANKRD17 MACF1 DDX20 EIF3H EIF4G3 ATP2A2 PRRC2A MOV10	2.29e-06	1149	149	18	35446349
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	BCORL1 ADNP2 ZNF362 MIDEAS CIC TAF3 PBRM1 CIZ1 KMT2A SMARCD2 CABIN1 MGA RAI1	2.40e-06	608	149	13	36089195
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	COPA SEC24A ROR2 CC2D1B USO1 PRRC2C SLC25A13 EIF4G1 ANKRD17 MACF1 EIF4G3 ATP2A2 PRRC2A MED12	2.40e-06	708	149	14	39231216
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	COPA MYO9B PRRC2C EIF4G1 ANKRD17 DOCK6 ATP2A2 PRRC2A	2.79e-06	202	149	8	33005030
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	COPA SEC24A U2SURP TACC2 NCAPH USP10 USO1 PRPF3 SUPT6H PRRC2C MRPS25 SLC25A13 SYNE2 EIF4G1 MACF1 DDX20 EIF3H ATP2A2 PRRC2A MAN1B1	2.87e-06	1415	149	20	28515276
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	COPA U2SURP BCORL1 REST MIDEAS CIC NCOR1 KMT2D PBRM1 ZIC5 PRPF3 SUPT6H SUPT7L CIZ1 KMT2A CABIN1 MGA ATP2A2 RAI1	3.01e-06	1294	149	19	30804502
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	SATB2 COPA MYO9B NCAPH CIC NCOR1 KMT2D USO1 PRRC2C EIF4G1 ANKRD17 CABIN1 MGA MOV10 FOXI1	4.55e-06	857	149	15	25609649
Pubmed	GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer.	MIDEAS PRKRA USP10 PRPF3 SLC25A13 SMARCD2 PRRC2A MOV10	5.78e-06	223	149	8	33731348
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	REST NCAPH TAF3 KMT2D PBRM1 SUPT6H PRRC2C KMT2A SMARCD2 EIF3H MOV10	6.20e-06	469	149	11	27634302
Pubmed	Identification of multi-SH3 domain-containing protein interactome in pancreatic cancer: a yeast two-hybrid approach.	LAMA5 PRR14 BRDT ITSN2 CIZ1 EIF4G3	6.70e-06	106	149	6	18654987
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	COPA APOB MIDEAS PRKRA USP10 TAF3 PBRM1 USO1 PRRC2C EIF4G1 MARF1 KMT2A ANKRD17 SMARCD2 DDX20 PRRC2A PRRC2B MOV10 TRPT1	6.88e-06	1371	149	19	36244648
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	COPA MYO9B U2SURP PRKRA NCOR1 USP10 TULP4 USO1 SIPA1L1 SLC25A13 EIF4G1 PAK1 ANKRD17 AFF1 MGA ATP2A2 PRRC2A MED12	7.07e-06	1247	149	18	27684187
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	U2SURP PRKRA USP10 MRPL15 PRPF3 PRRC2C MRPS25 SLC25A13 EIF4G1 ANKRD17 DDX20 PRRC2A MOV10	7.76e-06	678	149	13	30209976
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	PRKRA USP10 PRRC2C SIPA1L1 EIF4G1 MACF1 EIF3H PRRC2A MOV10	9.41e-06	315	149	9	26777405
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	SH3BP2 LAMA5 APOB MIDEAS PRKRA BRDT FUBP1 MACF1 DOCK6 PRRC2A ATP6V0A2	1.05e-05	496	149	11	31343991
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PPRC1 ASAP1 MAP3K4 SLC12A5 RPAP1 PRRC2C SIPA1L1 ITSN2 MACF1 PRRC2B	1.11e-05	407	149	10	12693553
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	COPA VTA1 NCAPH MAP3K4 PRKRA RPAP1 USO1 SLC25A13 ANKRD17 SMARCD2 EIF4G3 DNAH8 MOV10	1.16e-05	704	149	13	29955894
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	KMT2D PBRM1 KMT2A SMARCD2 MED12	1.22e-05	69	149	5	28481362
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SLC12A6 COPA ASAP1 SLC12A5 PRKRA USP10 USO1 PRRC2C SIPA1L1 ITSN2 EIF4G1 KMT2A MACF1 EIF4G3 TNNT2 ATP2A2 PRRC2A WNK2 PRRC2B	1.25e-05	1431	149	19	37142655
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	U2SURP TACC2 NCAPH CIC USP10 PRPF3 PRRC2C CIZ1 KMT2A ANKRD17 MACF1 PRR14L EIF4G3 PRRC2A PRRC2B	1.26e-05	934	149	15	33916271
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	NCOR1 RESF1 PRRC2C SYNE2 EIF4G1 EIF4G3	1.57e-05	123	149	6	26912792
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	SATB2 DAB2 SIPA1L1 ITSN2 DOCK6 FHIP1A	1.72e-05	125	149	6	29467281
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 CTC1 PPRC1 APOB TACC2 ASAP1 SH3PXD2B RESF1 SIPA1L1 UNC5C ANKRD17 AFF1 MACF1 MGA MAN1B1 ATP6V0A2	1.80e-05	1084	149	16	11544199
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	U2SURP LAMA5 NCOR1 USP10 PBRM1 PRPF3 EIF4G1 KMT2A ANKRD17 DDX20 ATP2A2 PRRC2A INO80B MOV10	1.81e-05	847	149	14	35850772
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	COPA U2SURP NCAPH PBRM1 MRPL15 SUPT6H PRRC2C FUBP1 EIF4G1 ANKRD17 MACF1 SMARCD2 EIF3H EIF4G3	1.81e-05	847	149	14	35235311
Pubmed	The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression.	KMT2A AFF1	1.82e-05	2	149	2	16169901
Pubmed	Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia.	KMT2A AFF1	1.82e-05	2	149	2	17889710
Pubmed	Autism-Misregulated eIF4G Microexons Control Synaptic Translation and Higher Order Cognitive Functions.	EIF4G1 EIF4G3	1.82e-05	2	149	2	31999954
Pubmed	Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2.	STAT2 STAT4	1.82e-05	2	149	2	10881177
Pubmed	Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo.	KMT2D KMT2A	1.82e-05	2	149	2	26711341
Pubmed	eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.	EIF4G1 EIF4G3	1.82e-05	2	149	2	10872469
Pubmed	Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product.	KMT2A AFF1	1.82e-05	2	149	2	7689231
Pubmed	Pak1 is required to maintain ventricular Ca²⁺ homeostasis and electrophysiological stability through SERCA2a regulation in mice.	PAK1 ATP2A2	1.82e-05	2	149	2	25217043
Pubmed	Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC.	USP10 EIF4G1	1.82e-05	2	149	2	27003362
Pubmed	Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6.	KMT2A AFF1	1.82e-05	2	149	2	11930009
Pubmed	Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.	KMT2D KMT2A	1.82e-05	2	149	2	24423662
Pubmed	Genetic and Epigenetic Characterization of a Discordant KMT2A/AFF1-Rearranged Infant Monozygotic Twin Pair.	KMT2A AFF1	1.82e-05	2	149	2	34575904
Pubmed	Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors.	CIC FUBP1	1.82e-05	2	149	2	24030748
Pubmed	MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.	KMT2A AFF1	1.82e-05	2	149	2	27856324
Pubmed	The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11).	KMT2A AFF1	1.82e-05	2	149	2	34489550
Pubmed	A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy.	KMT2A AFF1	1.82e-05	2	149	2	16551973
Pubmed	The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene.	KMT2A AFF1	1.82e-05	2	149	2	1423625
Pubmed	Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.	KMT2A AFF1	1.82e-05	2	149	2	9326653
Pubmed	Coexpression of EphA10 and Gli3 promotes breast cancer cell proliferation, invasion and migration.	GLI3 EPHA10	1.82e-05	2	149	2	33990369
Pubmed	Mutations in CIC and FUBP1 contribute to human oligodendroglioma.	CIC FUBP1	1.82e-05	2	149	2	21817013
Pubmed	Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.	KMT2A AFF1	1.82e-05	2	149	2	21135858
Pubmed	Amlexanox Downregulates S100A6 to Sensitize KMT2A/AFF1-Positive Acute Lymphoblastic Leukemia to TNFα Treatment.	KMT2A AFF1	1.82e-05	2	149	2	28646023
Pubmed	Establishment of MLL/AF4 transgenic mice with the phenotype of lymphoblastic leukemia or lymphoma.	KMT2A AFF1	1.82e-05	2	149	2	24189350
Pubmed	USP10 promotes cell proliferation, migration, and invasion in NSCLC through deubiquitination and stabilization of EIF4G1.	USP10 EIF4G1	1.82e-05	2	149	2	39390016
Pubmed	H3K79 methylation profiles define murine and human MLL-AF4 leukemias.	KMT2A AFF1	1.82e-05	2	149	2	18977325
Pubmed	Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein.	KMT2A AFF1	1.82e-05	2	149	2	14990976
Pubmed	CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas.	CIC FUBP1	1.82e-05	2	149	2	22588899
Pubmed	SPAG4L/SPAG4Lβ interacts with Nesprin2 to participate in the meiosis of spermatogenesis.	SPAG4 SYNE2	1.82e-05	2	149	2	31144711
Pubmed	A case of pediatric acute myeloid leukemia with t(11;16)(q23;q24) leading to a novel KMT2A-USP10 fusion gene.	USP10 KMT2A	1.82e-05	2	149	2	30107050
Interaction	QPRT interactions	NPL SATB2 U2SURP NCOR1 PRRC2C ANKRD17 SMARCD2 EIF4G3 ADAMTSL4	1.06e-08	84	147	9	int:QPRT
Interaction	KLF15 interactions	BCORL1 CCDC57 CIC NCOR1 KMT2D PBRM1 MRPL15 PRRC2C MRPS25 ZNF746 EIF3H MGA PRRC2A PRRC2B	2.87e-08	290	147	14	int:KLF15
Interaction	FEV interactions	SATB2 MIDEAS CIC NCOR1 TAF3 KMT2D PBRM1 ZNF746 KMT2A SMARCD2 MGA PRRC2B	3.22e-08	203	147	12	int:FEV
Interaction	ZC3H7A interactions	USP10 PRRC2C SLC25A13 EIF4G1 MARF1 PAK1 ANKRD17 UNK ATP2A2 PRRC2A PRRC2B MOV10	6.06e-08	215	147	12	int:ZC3H7A
Interaction	TOP3B interactions	USP34 CTC1 MYO9B PPRC1 SHISA5 SEC24A LAMA5 NBL1 APOB CIC NCOR1 USP10 SH3PXD2B KMT2D RPAP1 TULP4 SLC25A13 EIF4G1 ANKRD17 UNK DDX20 CABIN1 DOCK6 ADAMTSL4 PRRC2A MED12 WNK2 ARHGAP33 PRRC2B MOV10 RAI1	6.42e-08	1470	147	31	int:TOP3B
Interaction	YTHDF2 interactions	KLF8 NCAPH CIC USP10 PRRC2C GLI3 MARF1 ANKRD17 UNK EIF3H EIF4G3 PRRC2A PRRC2B MOV10	7.13e-08	312	147	14	int:YTHDF2
Interaction	SIRT7 interactions	USP34 COPA U2SURP PRKRA PBRM1 SUPT6H PRRC2C SLC25A13 SYNE2 EIF4G1 KMT2A ANKRD17 MACF1 DDX20 EIF4G3 ATP2A2 PRRC2A MED12 PRRC2B MOV10 RAI1	1.10e-07	744	147	21	int:SIRT7
Interaction	GATA3 interactions	SATB2 MIDEAS CIC NCOR1 KMT2D PBRM1 FUBP1 ZNF746 SMARCD2 PRRC2B MOV10	1.29e-07	187	147	11	int:GATA3
Interaction	CRX interactions	TRERF1 SATB2 ROR2 BCORL1 MIDEAS KMT2D PBRM1 SMARCD2 MGA MED12 PRRC2B RAI1	3.69e-07	254	147	12	int:CRX
Interaction	SP7 interactions	TRERF1 SATB2 MIDEAS CIC NCOR1 KMT2D PBRM1 FUBP1 SLC25A13 SMARCD2 MGA ATP2A2 PRRC2B	3.70e-07	304	147	13	int:SP7
Interaction	EGR2 interactions	TRERF1 BCORL1 MIDEAS NCOR1 KMT2D RESF1 ZNF746 KMT2A MGA PRRC2B	5.19e-07	171	147	10	int:EGR2
Interaction	NPM1 interactions	BDP1 MYO9B BCORL1 REST NCAPH CIC PRKRA IGSF10 USP10 TAF3 PBRM1 PRRC2C MRPS25 FUBP1 ZNF746 SYNE2 UNC5C CENPI EIF4G1 KMT2A AFF1 EIF3H PRRC2A INO80B PRRC2B MOV10	5.45e-07	1201	147	26	int:NPM1
Interaction	NFIX interactions	SATB2 MIDEAS CIC PRDM1 NCOR1 KMT2D PBRM1 ZNF746 KMT2A SMARCD2 MGA	8.98e-07	227	147	11	int:NFIX
Interaction	KLF8 interactions	KLF8 BCORL1 CIC TAF3 KMT2D PBRM1 PRRC2C EIF4G1 EIF3H MGA ATP2A2 PRRC2A PRRC2B	9.04e-07	329	147	13	int:KLF8
Interaction	HNF1B interactions	SATB2 MIDEAS CIC PRDM1 NCOR1 KMT2D PBRM1 CABIN1 MGA PRRC2B	1.36e-06	190	147	10	int:HNF1B
Interaction	PAX8 interactions	SATB2 MIDEAS CIC NCOR1 KMT2D PBRM1 SMARCD2 PRRC2B	1.55e-06	111	147	8	int:PAX8
Interaction	SOX7 interactions	SATB2 BCORL1 ADNP2 KMT2D PBRM1 RESF1 SMARCD2	2.29e-06	82	147	7	int:SOX7
Interaction	PAX6 interactions	SATB2 APOB MIDEAS CIC NCOR1 TAF3 KMT2D PBRM1 ZNF746 SMARCD2 CABIN1 MGA PRRC2B	2.94e-06	366	147	13	int:PAX6
Interaction	NUP43 interactions	USP34 MIDEAS NCOR1 TAF3 KMT2D PBRM1 RESF1 SUPT6H PRRC2C SYNE2 EIF4G1 CIZ1 MARF1 KMT2A EIF4G3 MGA MED12	3.25e-06	625	147	17	int:NUP43
Interaction	NFIC interactions	KLF8 SATB2 SEC24A MIDEAS CIC PRDM1 NCOR1 KMT2D SMARCD2 MGA	3.35e-06	210	147	10	int:NFIC
Interaction	SH3KBP1 interactions	SH3BP2 DAB2 CCDC57 MIDEAS ASAP1 MAP3K4 SH3PXD2B ITSN2 CIZ1 PAK1 PRRC2A MOV10	3.52e-06	315	147	12	int:SH3KBP1
Interaction	LHX4 interactions	SATB2 CIC NCOR1 KMT2D PBRM1 SMARCD2 MGA ADAMTSL4 INO80B	3.66e-06	166	147	9	int:LHX4
Interaction	EIF3C interactions	BDP1 KLF8 COPA NCAPH CIC USP10 MRPL15 EIF4G1 EIF3H EIF4G3 PRRC2B	3.75e-06	263	147	11	int:EIF3C
Interaction	HDAC1 interactions	TRERF1 SATB2 VTA1 REST INPP5F NCAPH MIDEAS CIC STAT2 PRDM1 NCOR1 KMT2D USO1 GLI3 SYNE2 KMT2A ANKRD17 AFF1 SMARCD2 CABIN1 MGA MED12 RAI1	5.41e-06	1108	147	23	int:HDAC1
Interaction	SOX17 interactions	SATB2 MIDEAS CIC NCOR1 KMT2D PBRM1 SMARCD2	6.15e-06	95	147	7	int:SOX17
Interaction	BMI1 interactions	BCORL1 SEC31B PRKRA SUPT6H PRRC2C EIF4G1 CIZ1 KMT2A SMARCD2 EIF3H EIF4G3 MGA PRRC2A MED12 MAN1B1 PRRC2B MOV10	6.55e-06	659	147	17	int:BMI1
Interaction	KLF3 interactions	SATB2 BCORL1 MIDEAS CIC NCOR1 TAF3 KMT2D PBRM1 KMT2A MGA	6.93e-06	228	147	10	int:KLF3
Interaction	NUP50 interactions	COPA NCAPH NCOR1 TAF3 PBRM1 SUPT6H ITSN2 EIF4G1 MARF1 KMT2A SMARCD2 RAI1	7.89e-06	341	147	12	int:NUP50
Interaction	ALG13 interactions	ROR2 NCOR1 KMT2D PRRC2C MARF1 UNK PRRC2A PRRC2B MOV10	8.09e-06	183	147	9	int:ALG13
Interaction	HDAC4 interactions	COPA BCORL1 REST NDUFB6 PRKRA NCOR1 USP10 AHRR PBRM1 PRRC2C SIPA1L1 SLC25A13 PAK1 UNK SMARCD2 DDX20 PRRC2A PRRC2B	8.30e-06	744	147	18	int:HDAC4
Interaction	LHX3 interactions	SATB2 MIDEAS CIC NCOR1 KMT2D PBRM1 SYNE2 SMARCD2 MGA	8.84e-06	185	147	9	int:LHX3
Interaction	E2F6 interactions	KLF8 BCORL1 CIC KMT2D PBRM1 BRDT KMT2A MGA INO80B	8.84e-06	185	147	9	int:E2F6
Interaction	OTUD4 interactions	IQCN CIC USP10 PRRC2C GLI3 ANKRD17 UNK PRRC2A PRRC2B MOV10	9.38e-06	236	147	10	int:OTUD4
Interaction	UNK interactions	USP34 COPA SEC24A USP10 PRRC2C EIF4G1 ANKRD17 UNK EIF3H MGA ATP2A2 PRRC2A PRRC2B	9.51e-06	408	147	13	int:UNK
Interaction	NFIB interactions	KLF8 SATB2 MIDEAS CIC NCOR1 KMT2D UNK SMARCD2	9.74e-06	142	147	8	int:NFIB
Interaction	NFIA interactions	KLF8 SATB2 MIDEAS CIC PRDM1 NCOR1 KMT2D SMARCD2 FOXI1	1.01e-05	188	147	9	int:NFIA
Interaction	GCM1 interactions	MIDEAS CIC NCOR1 KMT2D SMARCD2 PRRC2B	1.03e-05	68	147	6	int:GCM1
Interaction	DAZL interactions	USP10 PRRC2C FUBP1 ANKRD17 EIF4G3 PRRC2A PRRC2B MOV10	1.14e-05	145	147	8	int:DAZL
Interaction	NANOG interactions	TRERF1 USP34 SATB2 REST MIDEAS NCOR1 PBRM1 RESF1 SUPT6H SLC25A13 DDX20 MGA MED12 MOV10	1.19e-05	481	147	14	int:NANOG
Interaction	EIF3D interactions	KLF8 CCDC57 CIC USP10 ZNF746 EIF4G1 EIF3H EIF4G3 DOCK6 PRRC2B	1.25e-05	244	147	10	int:EIF3D
Interaction	PYHIN1 interactions	SATB2 COPA U2SURP LAMA5 PRPF3 SUPT6H ANKRD17 CABIN1 MGA PRRC2B MOV10 RAI1	1.28e-05	358	147	12	int:PYHIN1
Interaction	MYOD1 interactions	MIDEAS NCOR1 TAF3 KMT2D PBRM1 ZNF746 SMARCD2 CABIN1 MGA	1.29e-05	194	147	9	int:MYOD1
Interaction	EIF4ENIF1 interactions	PRRC2C GLI3 EIF4G1 MARF1 ANKRD17 UNK EIF3H EIF4G3 PRRC2A PRRC2B MOV10	1.30e-05	300	147	11	int:EIF4ENIF1
Interaction	YTHDF1 interactions	IQCN USP10 PRRC2C GLI3 ITSN2 MARF1 ANKRD17 UNK PRRC2A PRRC2B MOV10	1.39e-05	302	147	11	int:YTHDF1
Interaction	FOXL1 interactions	SATB2 COPA MYO9B NCAPH MIDEAS CIC NCOR1 KMT2D EIF4G1	1.40e-05	196	147	9	int:FOXL1
Interaction	EIF3G interactions	KLF8 NCAPH CIC USP10 PRRC2C EIF4G1 EIF3H EIF4G3 PRRC2A PRRC2B	1.49e-05	249	147	10	int:EIF3G
Interaction	GATA2 interactions	SATB2 MIDEAS CIC NCOR1 KMT2D PBRM1 SMARCD2 ADAMTSL4 PRRC2B	1.59e-05	199	147	9	int:GATA2
Interaction	RCOR1 interactions	USP34 SATB2 BCORL1 VTA1 REST NCAPH CIC PRDM1 NCOR1 KMT2D RESF1 ANKRD17 MGA MED12	1.60e-05	494	147	14	int:RCOR1
Interaction	HDAC2 interactions	KLF8 SATB2 COPA REST NCAPH MIDEAS CIC PRDM1 NCOR1 PRRC2C FUBP1 KMT2A ANKRD17 UNK SMARCD2 DDX20 CABIN1 MOV10 RAI1	1.78e-05	865	147	19	int:HDAC2
Interaction	TBR1 interactions	SATB2 MIDEAS CIC NCOR1 KMT2D BRDT SMARCD2	1.93e-05	113	147	7	int:TBR1
Interaction	ELF4 interactions	CIC TAF3 KMT2D PBRM1 SUPT7L SMARCD2 MGA	2.16e-05	115	147	7	int:ELF4
Interaction	LSM14A interactions	KLF8 CIC USP10 PRRC2C MARF1 ANKRD17 UNK PRRC2A PRRC2B MOV10	2.17e-05	260	147	10	int:LSM14A
Interaction	TBXT interactions	SATB2 MIDEAS CIC NCOR1 KMT2D ZNF746 SMARCD2	2.29e-05	116	147	7	int:TBXT
Interaction	EIF3E interactions	KLF8 NCAPH CIC ZNF746 EIF4G1 UNK EIF3H EIF4G3 PRRC2A PRRC2B	2.39e-05	263	147	10	int:EIF3E
Interaction	MKRN2 interactions	SATB2 ASAP1 USP10 PRRC2C GLI3 SYNE2 UNC5C MARF1 MACF1 PRRC2A PRRC2B MOV10	2.63e-05	385	147	12	int:MKRN2
Interaction	RUNX1 interactions	COPA U2SURP SEC31B CIC NCOR1 USP10 FUBP1 FAM222B KMT2A PRRC2A MED12	2.66e-05	324	147	11	int:RUNX1
Interaction	G3BP2 interactions	KLF8 REST USP10 PRRC2C FUBP1 SLC25A13 EIF4G1 UNK EIF3H ATP2A2 PRRC2A MED12 PRRC2B MOV10	2.70e-05	518	147	14	int:G3BP2
Interaction	ELK3 interactions	SATB2 BCORL1 CIC TAF3 PBRM1 ZNF746 MGA	2.85e-05	120	147	7	int:ELK3
Interaction	CEP85 interactions	NCAPH GLI3 MARF1 ANKRD17 UNK PRRC2A PRRC2B MOV10	3.43e-05	169	147	8	int:CEP85
Interaction	SOX2 interactions	TRERF1 USP34 SATB2 COPA MYO9B ZNF362 MIDEAS CIC PRKRA NCOR1 PRR14 KMT2D PBRM1 MRPL15 FUBP1 GLI3 SIPA1L1 MARF1 PAK1 KMT2A ANKRD17 MACF1 SMARCD2 EIF4G3 PRRC2B	3.47e-05	1422	147	25	int:SOX2
Interaction	HNF4A interactions	SATB2 MIDEAS CIC NCOR1 TAF3 KMT2D PBRM1 SMARCD2 CABIN1 MGA	3.50e-05	275	147	10	int:HNF4A
Interaction	PAX7 interactions	SATB2 MIDEAS CIC NCOR1 KMT2D ZNF746 SMARCD2	3.52e-05	124	147	7	int:PAX7
Interaction	AR interactions	TRERF1 USP34 U2SURP ZNF362 MIDEAS CIC NCOR1 USP10 KMT2D PBRM1 PRPF3 FUBP1 GLI3 SUPT7L KMT2A SMARCD2 MGA MED12 PRRC2B RAI1	3.58e-05	992	147	20	int:AR
Interaction	IRF4 interactions	SATB2 CIC PRDM1 KMT2D PBRM1 PRRC2B	3.70e-05	85	147	6	int:IRF4
Interaction	EIF4A2 interactions	USP10 PRRC2C EIF4G1 UNK EIF3H EIF4G3 PRRC2A PRRC2B	3.74e-05	171	147	8	int:EIF4A2
Interaction	ERG interactions	SATB2 MIDEAS CIC NCOR1 KMT2D RESF1 ZNF746 SMARCD2 PRRC2B	3.89e-05	223	147	9	int:ERG
Interaction	EIF3H interactions	BDP1 KLF8 NCAPH CIC SLC25A13 EIF4G1 UNK EIF3H EIF4G3 PRRC2B	4.32e-05	282	147	10	int:EIF3H
Interaction	TEAD1 interactions	SATB2 MIDEAS CIC NCOR1 KMT2D PBRM1 SMARCD2 MGA	4.58e-05	176	147	8	int:TEAD1
Interaction	PAX9 interactions	SATB2 MIDEAS CIC NCOR1 KMT2D PBRM1 SMARCD2	4.76e-05	130	147	7	int:PAX9
Interaction	MYCN interactions	U2SURP APOB ZNF362 ZNF385A INPP5F MIDEAS PRKRA MRPL15 PRPF3 PRRC2C MRPS25 FUBP1 SLC25A13 MARF1 KMT2A ANKRD17 SMARCD2 EIF4G3 ATP2A2 PRRC2A INO80B PRRC2B MOV10 RAI1	5.58e-05	1373	147	24	int:MYCN
Interaction	LHX2 interactions	SATB2 BCORL1 CIC NCOR1 KMT2D PBRM1 SMARCD2 MGA	6.04e-05	183	147	8	int:LHX2
Interaction	EIF3A interactions	KLF8 NCAPH CIC NCOR1 USP10 PRRC2C ZNF746 EIF4G1 UNK EIF3H EIF4G3	6.08e-05	355	147	11	int:EIF3A
Interaction	LHX6 interactions	SATB2 ROR2 BCORL1 CIC PBRM1	6.47e-05	58	147	5	int:LHX6
Interaction	BRD7 interactions	CTC1 MYO9B U2SURP USP10 SH3PXD2B PBRM1 PRPF3 PRRC2C SLC25A13 EIF4G1 SMARCD2 DDX20 PRRC2A MOV10 FOXI1	6.68e-05	637	147	15	int:BRD7
Interaction	NUP35 interactions	USP34 SEC24A MIDEAS CIC NCOR1 KMT2D PRRC2C FUBP1 FAM222B ANKRD17 PRRC2B RAI1	6.69e-05	424	147	12	int:NUP35
Interaction	SOX9 interactions	MIDEAS CIC KMT2D PBRM1 SMARCD2 MED12	7.79e-05	97	147	6	int:SOX9
Interaction	RPS16 interactions	U2SURP REST NCAPH CIC USP10 PBRM1 PRPF3 PRRC2C FUBP1 ZNF746 EIF4G1 ANKRD17 EIF3H PRRC2A INO80B PRRC2B	7.99e-05	724	147	16	int:RPS16
Interaction	YTHDF3 interactions	KLF8 USP10 PRRC2C MARF1 ANKRD17 UNK PRRC2A PRRC2B MOV10	8.29e-05	246	147	9	int:YTHDF3
Interaction	TLX2 interactions	SATB2 MIDEAS CIC NCOR1 KMT2D PBRM1 MOV10	8.33e-05	142	147	7	int:TLX2
Interaction	RPS11 interactions	KLF8 REST NCAPH CIC PRKRA PRRC2C GLI3 ZNF746 EIF4G1 EIF3H PRRC2A PRRC2B MOV10	8.64e-05	505	147	13	int:RPS11
Interaction	ASF1A interactions	BDP1 BCORL1 ZNF362 NCOR1 KMT2D KMT2A CABIN1 MGA RAI1	9.09e-05	249	147	9	int:ASF1A
Interaction	IGF2BP1 interactions	REST PRKRA NCOR1 USP10 RPAP1 PRRC2C FUBP1 ZNF746 MARF1 PRRC2A MAN1B1 PRRC2B MOV10	9.17e-05	508	147	13	int:IGF2BP1
Interaction	KLF5 interactions	CIC NCOR1 KMT2D PBRM1 SMARCD2 MGA PRRC2A PRRC2B	9.42e-05	195	147	8	int:KLF5
Interaction	CPEB1 interactions	PRRC2C MARF1 ANKRD17 UNK PRRC2A PRRC2B MOV10	9.91e-05	146	147	7	int:CPEB1
Interaction	TLE3 interactions	TRERF1 SEC24A BCORL1 ZNF362 MIDEAS CIC PRDM1 NCOR1 KMT2D KMT2A FOXI1	1.01e-04	376	147	11	int:TLE3
Interaction	RC3H2 interactions	U2SURP HPSE PRKRA USP10 PRPF3 PRRC2C MRPS25 SLC25A13 EIF4G1 ANKRD17 UNK DDX20 PRRC2A PRRC2B MOV10	1.11e-04	667	147	15	int:RC3H2
Interaction	GRM2 interactions	COPA U2SURP REST USP10 MRPL15 MRPS25 SLC25A13 DDX20 ATP2A2 PRRC2A MOV10	1.14e-04	381	147	11	int:GRM2
Interaction	SMC5 interactions	U2SURP BCORL1 ZNF362 MIDEAS CIC NCOR1 TAF3 PRPF3 PRRC2C FUBP1 EIF4G1 CIZ1 MARF1 KMT2A MGA ATP2A2 PRRC2A INO80B RAI1	1.25e-04	1000	147	19	int:SMC5
Interaction	TAF1 interactions	SH3BP2 ZNF362 CIC TAF3 KMT2D GLI3 KMT2A EIF3H MOV10	1.26e-04	260	147	9	int:TAF1
Interaction	CREBBP interactions	TRERF1 KLF8 TACC2 STAT2 STAT4 NCOR1 KMT2D SUPT6H GLI3 MED25 MARF1 KMT2A MGA FOXI1	1.28e-04	599	147	14	int:CREBBP
Interaction	G3BP1 interactions	KLF8 COPA CC2D1B PRKRA USP10 PRRC2C SIPA1L1 SLC25A13 EIF4G1 ANKRD17 UNK MACF1 EIF3H ATP2A2 PRRC2A PRRC2B MOV10	1.28e-04	835	147	17	int:G3BP1
Interaction	RC3H1 interactions	U2SURP NCAPH PRKRA USP10 SH3PXD2B MRPL15 PRRC2C MRPS25 EIF4G1 ANKRD17 UNK MGA PRRC2A PRRC2B MOV10	1.31e-04	677	147	15	int:RC3H1
Interaction	LRRC31 interactions	COPA MYO9B PRRC2C EIF4G1 ANKRD17 DOCK6 ATP2A2 PRRC2A	1.33e-04	205	147	8	int:LRRC31
Interaction	CD74 interactions	COPA NCAPH PRRC2C EIF4G1 EIF3H PRRC2A PRRC2B	1.38e-04	154	147	7	int:CD74
Interaction	YAP1 interactions	TRERF1 COPA NCAPH MIDEAS NCOR1 USP10 TAF3 KMT2D TULP4 PRRC2C FUBP1 CIZ1 KMT2A UNK EIF3H MGA PRRC2A MED12 MOV10 FOXI1	1.39e-04	1095	147	20	int:YAP1
Interaction	PCGF1 interactions	USP34 KLF8 SATB2 BCORL1 STAT4 PRDM1 MGA FOXI1	1.47e-04	208	147	8	int:PCGF1
Interaction	CPEB4 interactions	PRRC2C MARF1 ANKRD17 UNK PRRC2A PRRC2B MOV10	1.50e-04	156	147	7	int:CPEB4
Interaction	FMR1 interactions	TACC2 NCOR1 USP10 PBRM1 PRRC2C FUBP1 EIF4G1 ANKRD17 UNK MACF1 PRRC2A PRRC2B MOV10	1.56e-04	536	147	13	int:FMR1
Interaction	EN1 interactions	MIDEAS CIC NCOR1 KMT2D KMT2A MGA	1.56e-04	110	147	6	int:EN1
Interaction	TDRD3 interactions	USP10 PRRC2C MARF1 ANKRD17 UNK PRRC2A PRRC2B MOV10	1.68e-04	212	147	8	int:TDRD3
GeneFamily	SH2 domain containing	SH3BP2 LCP2 STAT2 STAT4 CISH SUPT6H	1.71e-05	101	97	6	741
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	TRERF1 BDP1 MIDEAS NCOR1	1.86e-04	53	97	4	532
Coexpression	GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP	SLC12A6 SHISA5 SH3BP2 STAT2 RESF1 USO1 ITSN2 TNNT2 ATP2A2 MOV10	2.05e-07	200	147	10	M9023
Coexpression	GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN	MSR1 GPATCH3 ZIC5 MRPS25 FAM222B SLC25A13 FHIP1A ATP6V0A2	1.16e-06	138	147	8	M2912
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	USP34 SATB2 MYO9B SEC24A RHOBTB3 U2SURP INPP5F MAP3K4 PRRC2C FUBP1 SIPA1L1 SLC25A13 SYNE2 ITSN2 ANKRD17 AFF1 MACF1 EIF4G3	1.56e-06	856	147	18	M4500
Coexpression	MULLIGHAN_MLL_SIGNATURE_2_DN	USP34 DAB2 LAMA5 NBL1 AREG STAT4 SIPA1L1 KMT2A MACF1 ATP2A2	4.19e-06	279	147	10	M16867
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	MYO9B NCOR1 TULP4 PRRC2C SIPA1L1 MACF1 PRR14L ATP2A2	8.37e-06	180	147	8	M8239
Coexpression	YAGI_AML_WITH_T_8_21_TRANSLOCATION	ADNP2 LAMA5 NBL1 APOB AREG USP10 SIPA1L1 KMT2A MACF1 SMARCD2 MED12	8.59e-06	372	147	11	M19261
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	SATB2 SEC24A U2SURP INPP5F PRRC2C FUBP1 SLC25A13 ITSN2 MARF1 ANKRD17 AFF1 EIF4G3	1.33e-05	466	147	12	M13522
Coexpression	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP	STOX1 ZIC5 SYNE2 MARF1 PRR14L DOCK6 MED12 RAI1	1.67e-05	198	147	8	M9929
Coexpression	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	SHISA5 NCOR1 PRR14 KMT2D PRRC2C EIF4G3 PRRC2B RAI1	1.74e-05	199	147	8	M9443
Coexpression	GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN	PPRC1 PODXL2 MSR1 NCOR1 USO1 KMT2A ANKRD17 PRRC2B	1.80e-05	200	147	8	M5806
Coexpression	GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	LAMA5 CIC STAT2 PRDM1 FUBP1 SIPA1L1 ATP2A2 DNAH8	1.80e-05	200	147	8	M6243
Coexpression	HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_NEGATIVE	DAB2 IGSF10 RAI1	2.01e-05	10	147	3	M41091
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	MYO9B PPRC1 SH3BP2 CC2D1B SEC31B CIC KMT2D MRPS25 SUPT7L PRRC2A	2.22e-05	338	147	10	M17094
Coexpression	HUTTMANN_B_CLL_POOR_SURVIVAL_UP	SPAG4 MYO9B RHOBTB3 LAMA5 PAK1 CABIN1 PRRC2A INO80B MAN1B1	3.39e-05	284	147	9	M19993
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	NPIPB15 CTC1 MYO9B ZNF362 IQCN MIDEAS STAT2 PRR14 ZNF746 MED25 UNK ATP2A2 MAN1B1 ARHGAP33 RAI1 TRPT1	5.11e-05	905	147	16	M40865
Coexpression	MULLIGHAN_MLL_SIGNATURE_1_DN	USP34 ADNP2 LAMA5 NBL1 AREG STAT4 SIPA1L1 KMT2A	6.19e-05	238	147	8	M18841
Coexpression	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN	SLC12A6 KLF8 SPAG4 ZNF362 CCDC57 EIF3H TRPT1	8.93e-05	186	147	7	M7938
Coexpression	GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP	IL11 CC2D1B CISH WFDC3 ADAMTSL4 INO80B ATP6V0A2	1.28e-04	197	147	7	M8586
Coexpression	GSE3982_MAST_CELL_VS_NEUTROPHIL_DN	SLC12A6 LARP6 ASAP1 SYNE2 MED25 MARF1 CABIN1	1.28e-04	197	147	7	M5433
Coexpression	GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	USP34 INPP5F LCP2 NDUFB6 AFF1 MACF1 GOLGA8A	1.36e-04	199	147	7	M8381
Coexpression	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	MYO9B ASAP1 SUPT6H EIF4G1 KMT2A MACF1 ATP2A2	1.36e-04	199	147	7	M9964
Coexpression	GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN	SLC12A6 MAP3K4 KMT2D RPAP1 KMT2A SMARCD2 PRRC2B	1.36e-04	199	147	7	M7319
Coexpression	GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN	SHISA5 BCORL1 BRDT SYNE2 KMT2A DNAH8 RAI1	1.36e-04	199	147	7	M7498
Coexpression	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	RHOBTB3 SH3BP2 U2SURP ADNP2 GPATCH3 ANKRD17 ATP2A2	1.36e-04	199	147	7	M8974
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP	ADNP2 LAMA5 REST STAT4 FAM222B ANKRD17 KEL	1.36e-04	199	147	7	M4037
Coexpression	GSE11924_TFH_VS_TH17_CD4_TCELL_UP	CC2D1B KMT2D PBRM1 CIZ1 AFF1 FHIP1A MAN1B1	1.36e-04	199	147	7	M3156
Coexpression	GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	SHISA5 RHOBTB3 TACC2 CISH PRR14L RAI1 TRPT1	1.40e-04	200	147	7	M302
Coexpression	GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN	TACC2 STAT4 ASAP1 RPAP1 SYNE2 UNK TNNT2	1.40e-04	200	147	7	M7025
Coexpression	GSE339_CD8POS_VS_CD4CD8DN_DC_DN	SHISA5 MDM1 APOB ZNF362 LCP2 GLI3 MOV10	1.40e-04	200	147	7	M5118
Coexpression	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	LAMA5 CIC MRPS25 SIPA1L1 SMARCD2 ATP2A2 DNAH8	1.40e-04	200	147	7	M6248
Coexpression	GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP	PPRC1 ADNP2 MAP3K4 PRKRA SUPT7L MACF1 ATP2A2	1.40e-04	200	147	7	M4488
Coexpression	MEBARKI_HCC_PROGENITOR_WNT_DN	APOB TACC2 IQCN STOX1 EPHA10	1.72e-04	92	147	5	M38983
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 SEC31B STAT4 MAP3K4 PRDM1 PRRC2C SYNE2 KMT2A MACF1 GOLGA8A	1.24e-09	197	148	10	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 USP34 STAT2 RESF1 PRRC2C SYNE2 ITSN2 KMT2A MACF1 GOLGA8A	1.44e-09	200	148	10	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	STAT4 PRDM1 RESF1 PRRC2C SYNE2 KMT2A MACF1 GOLGA8A	4.23e-08	151	148	8	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 BCORL1 NCAPH SLC12A5 SYNE2 DNAH8 ARHGAP33	1.94e-06	174	148	7	9d5dcd46cf346c381dea68ada6665f7fb68114a3
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 BCORL1 NCAPH SLC12A5 SYNE2 DNAH8 ARHGAP33	1.94e-06	174	148	7	53cec5c666c45278a71c21dd9c62a052a97e0fdf
ToppCell	COVID-19-lung-Macrophage_PPARGhi_CD5Lhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NPL MYO9B LCP2 MSR1 SH3PXD2B SPOCD1 ADAMTSL4	3.72e-06	192	148	7	bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4\|Lung / Manually curated celltypes from each tissue	NBL1 STAT4 PRDM1 RESF1 SYNE2 KMT2A GOLGA8A	3.72e-06	192	148	7	fd19cd0b5330448bef8debd753285adbc8b958a2
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP34 MYO9B ASAP1 SIPA1L1 ANKRD17 AFF1 EIF4G3	3.85e-06	193	148	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CTC1 SEC31B STAT4 MAP3K4 SYNE2 MACF1 GOLGA8A	3.85e-06	193	148	7	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 TULP4 PRRC2C KMT2A MACF1 MGA ATP2A2	4.12e-06	195	148	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	STAT4 PRDM1 RESF1 SYNE2 KMT2A MACF1 GOLGA8A	4.40e-06	197	148	7	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	STAT4 PRDM1 RESF1 SYNE2 KMT2A MACF1 GOLGA8A	4.40e-06	197	148	7	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	Adult-Immune\|Adult / Lineage, Cell type, age group and donor	MYO9B SH3BP2 LCP2 ASAP1 MSR1 SH3PXD2B ADAMTSL4	4.55e-06	198	148	7	9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 USP34 STAT4 PRRC2C SYNE2 MACF1 GOLGA8A	4.70e-06	199	148	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	mild-CD4+_Tcm\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PRDM1 RESF1 PRRC2C SYNE2 KMT2A MACF1 GOLGA8A	4.70e-06	199	148	7	06c8a0e39f7a33736548f04a5e2263334c8541cf
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 STAT4 PRDM1 RESF1 SYNE2 MACF1 GOLGA8A	4.70e-06	199	148	7	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	STAT4 PRDM1 RESF1 PRRC2C SYNE2 KMT2A MACF1	4.86e-06	200	148	7	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	mLN-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	SHISA5 LCP2 MSR1 SH3PXD2B RESF1 MRPL15 PRRC2C	4.86e-06	200	148	7	e3c15e0e1c2602b0cc9ab8cc50c978d265350c94
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	STAT4 RESF1 PRRC2C SYNE2 KMT2A MACF1 GOLGA8A	4.86e-06	200	148	7	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	SHISA5 STAT2 RESF1 PRRC2C SYNE2 KMT2A MACF1	4.86e-06	200	148	7	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Myeloid-macrophage\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPL DAB2 PRDM1 MSR1 CCDC89 INO80B	1.24e-05	153	148	6	4b999892fb797e9f0d391630094f466463299d57
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Myeloid-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPL DAB2 PRDM1 MSR1 CCDC89 INO80B	1.24e-05	153	148	6	e426db29e4ba83e7930dc88c74fc975b177c9540
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Myeloid\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPL DAB2 PRDM1 MSR1 CCDC89 INO80B	1.24e-05	153	148	6	668eacd76aad6054bd7d57e3af0b122c2443465f
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SATB2 LAMA5 PANX2 RPAP1 GOLGA8A MOV10	1.24e-05	153	148	6	8bc09b8b1a32a8d7ac8201c626d2b306e7cc2972
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	APOB STAT4 PRRC2C SYNE2 MACF1 GOLGA8A	2.33e-05	171	148	6	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SATB2 MYO9B DAB2 MSR1 SPOCD1 ADAMTSL4	2.57e-05	174	148	6	d5c22b43531414951666ee7542a66ed9380e2d14
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL11 LAMA5 PANX2 NCAPH GOLGA8A ATP2A2	2.57e-05	174	148	6	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	CF-Myeloid-Neutrophil\|Myeloid / Disease state, Lineage and Cell class	NPL SLC12A6 LCP2 RESF1 SLC25A13 SYNE2	2.65e-05	175	148	6	8020c3a34f77e68e8149f87481fb1dddd2ac675e
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTC1 NBL1 SLC12A5 SCGB3A2 SUPT7L FHIP1A	2.65e-05	175	148	6	31f0fb2e47e357dbf9c15436b7df85b3c370ded7
ToppCell	droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHISA5 RHOBTB3 STAT4 PRRC2C KMT2A MACF1	2.92e-05	178	148	6	8aef208b6351143562c87715bb11628880abce94
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HPSE IGSF10 PRRC2C KMT2A MACF1 DOCK6	3.11e-05	180	148	6	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	IIH-CD8-CD4_Treg\|IIH / Condition, Cell_class and T cell subcluster	PPRC1 BCORL1 NCAPH HPSE DDX20 BRICD5	3.11e-05	180	148	6	d1a8b25115c80e5a5bd0b8244167a98250ab9778
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HPSE IGSF10 PRRC2C KMT2A MACF1 DOCK6	3.11e-05	180	148	6	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASAP1 MSR1 PRRC2C ITSN2 MACF1 EIF4G3	3.30e-05	182	148	6	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 PRRC2C ITSN2 KMT2A MACF1 EIF4G3	3.51e-05	184	148	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASAP1 MSR1 PRRC2C ITSN2 MACF1 EIF4G3	3.62e-05	185	148	6	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRERF1 LCP2 STAT4 PRDM1 RESF1 SYNE2	4.08e-05	189	148	6	df30478b288084a1bd48f660409dcc784040897c
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17\|Lung / Manually curated celltypes from each tissue	NBL1 STAT4 RESF1 SYNE2 KMT2A GOLGA8A	4.08e-05	189	148	6	f43960506ed3e699e910ec7711c1113e2e9b80d1
ToppCell	COVID-19-lung-Macrophage_PPARGhi_CD5Lhi\|lung / Disease (COVID-19 only), tissue and cell type	NPL MYO9B MSR1 SH3PXD2B SPOCD1 ADAMTSL4	4.32e-05	191	148	6	dab953682b8c9ed680a799161f837f792a7e4f33
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175\|Adult / Lineage, Cell type, age group and donor	NPL MYO9B SH3BP2 LCP2 ASAP1 MSR1	4.45e-05	192	148	6	733491e932350e3c216a626cc49c3cd3fe970a82
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122\|Adult / Lineage, Cell type, age group and donor	NPL MYO9B MSR1 SH3PXD2B SPOCD1 ADAMTSL4	4.58e-05	193	148	6	cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)\|Adult / Lineage, Cell type, age group and donor	NPL MYO9B DAB2 LCP2 MSR1 SH3PXD2B	4.58e-05	193	148	6	31c0978ba78c9516d498aec0798902e57555e557
ToppCell	RA-08._Macrophage\|World / Chamber and Cluster_Paper	NPL MYO9B LCP2 AREG MSR1 SIPA1L1	4.58e-05	193	148	6	5fd22db1825d105709fcc0aa4955c99a117e3c82
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRERF1 LCP2 STAT4 PRDM1 RESF1 SYNE2	4.58e-05	193	148	6	b9769b45125d2244afe53f9f71c92c04ddccf980
ToppCell	droplet-Pancreas-Endocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA CISH NCOR1 EIF4G1 ATP2A2 PRRC2B	4.72e-05	194	148	6	3a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell	medial-2-Hematologic-EREG+_Dendritic\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NPIPB9 LCP2 HPSE AREG SLC12A5 SH3PXD2B	4.72e-05	194	148	6	b2b4e4c3ac0df0d9f17b930ffb60c0fd85b3dd78
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BDP1 USP34 PODXL2 ASAP1 PRRC2C MACF1	4.72e-05	194	148	6	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	medial-Hematologic-EREG+_Dendritic-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NPIPB9 LCP2 HPSE AREG SLC12A5 SH3PXD2B	4.72e-05	194	148	6	15f3b6b6579e388d0820f05e93a77ee1634bd6c3
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ROR2 TACC2 STAT4 TNNT2 ATP2A2 WNK2	4.72e-05	194	148	6	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	medial-Hematologic-EREG+_Dendritic\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NPIPB9 LCP2 HPSE AREG SLC12A5 SH3PXD2B	4.72e-05	194	148	6	1f3d22292d2691f93aa7b6770f5c250a33db3cc0
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA CISH NCOR1 EIF4G1 ATP2A2 PRRC2B	4.72e-05	194	148	6	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPL MYO9B LCP2 MSR1 SH3PXD2B SIPA1L1	4.72e-05	194	148	6	45708cb2cafde10bf4e4798b81d47c3b1f6aaa14
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	TACC2 CFAP61 TNNT2 ATP2A2 FHIP1A WNK2	4.85e-05	195	148	6	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	NPL MYO9B LCP2 MSR1 SH3PXD2B SIPA1L1	4.85e-05	195	148	6	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	NPL MYO9B LCP2 MSR1 SH3PXD2B SIPA1L1	4.85e-05	195	148	6	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOR1 PRRC2C KMT2A MACF1 MGA ATP2A2	4.85e-05	195	148	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	PRDM1 CISH RESF1 SYNE2 KMT2A GOLGA8A	4.85e-05	195	148	6	22191d361af136942508f1553ff41a626ed982ad
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	USP34 STAT4 TULP4 PRRC2C SYNE2 KMT2A	4.85e-05	195	148	6	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	distal-2-Hematologic-EREG+_Dendritic\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZNF385A LCP2 HPSE AREG SH3PXD2B SIPA1L1	5.14e-05	197	148	6	6fcca7c071e35786b715adeb18be317d34315d7e
ToppCell	mild-Treg\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PRDM1 RESF1 TULP4 SYNE2 KMT2A GOLGA8A	5.14e-05	197	148	6	39800e6e83f2d333b753d121c7aeb2912b91faa2
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LCP2 AREG STAT4 PRDM1 RESF1 SYNE2	5.14e-05	197	148	6	51340570667914bffec741c72a8d09cc46abb8e8
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC12A6 INPP5F PRDM1 CISH GOLGA8A DNAH8	5.14e-05	197	148	6	54fb7197db3c0dc87a1114e1ab1d2bfafd564b35
ToppCell	COVID_vent-Lymphocytic-T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	CISH RESF1 SYNE2 KMT2A MACF1 GOLGA8A	5.14e-05	197	148	6	ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	APOB RESF1 SYNE2 MACF1 GOLGA8A	5.26e-05	121	148	5	19333a660800b583fa27b495c1f7828e6636a257
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RHOBTB3 AREG STAT4 PRDM1 SYNE2 MACF1	5.28e-05	198	148	6	c54da37aa11f82a68e591d563b3db9121d6b498f
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RHOBTB3 AREG STAT4 PRDM1 SYNE2 MACF1	5.28e-05	198	148	6	58d805e827299292750b09c6283fdbe406b75f79
ToppCell	T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	LCP2 STAT4 RESF1 SYNE2 KMT2A MACF1	5.28e-05	198	148	6	1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RHOBTB3 AREG STAT4 PRDM1 SYNE2 MACF1	5.28e-05	198	148	6	90023468f3498548a92d75928f476b4157bde813
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL11 LCP2 STAT4 PRDM1 RESF1 SYNE2	5.28e-05	198	148	6	7608f67959e1cda7b10e57fd3af2f96216ebe7e9
ToppCell	wk_20-22-Hematologic-Myeloid-SPP1+_Mac\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NPL MYO9B DAB2 SLC12A5 PRDM1 MSR1	5.43e-05	199	148	6	7c19f1b1f4369edd035ca9cdcf4e653771fc4648
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	STAT4 RESF1 SYNE2 KMT2A MACF1 GOLGA8A	5.43e-05	199	148	6	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	U2SURP REST NCOR1 PRRC2C SYNE2 ITSN2	5.43e-05	199	148	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	wk_15-18-Hematologic-Myeloid-SPP1+_Mac\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NPL MYO9B DAB2 SLC12A5 PRDM1 MSR1	5.43e-05	199	148	6	c7fc2ac1601346aac71e7620a8a440fde8d92dbd
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	USP34 RESF1 SYNE2 KMT2A MACF1 DOCK6	5.58e-05	200	148	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	COVID-19\|World / group, cell type (main and fine annotations)	NPL ROR2 ASAP1 MSR1 SH3PXD2B EIF4G3	5.58e-05	200	148	6	ac38a468559c33ee00152735ce6e408f3f48df84
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	AREG RESF1 PRRC2C SYNE2 KMT2A MACF1	5.58e-05	200	148	6	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SH3BP2 LCP2 PRDM1 WFDC3 FUBP1	5.92e-05	124	148	5	1483be8700eca7e2c288784a290d945d4022b17f
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	PRRC2C SYNE2 MACF1 GOLGA8A FOXI1	8.85e-05	135	148	5	ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KLF8 PODXL2 EFCAB12 SYNE2 CFAP61	9.48e-05	137	148	5	761cc0e2b4971e98f6d0691d4575b5cd208b602d
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LARP6 PRDM1 RESF1 TULP4 SYNE2	1.24e-04	145	148	5	734d85ca7a2e5e040f433cadc5f9be1f25cf2e91
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LARP6 PRDM1 RESF1 TULP4 SYNE2	1.24e-04	145	148	5	8ba09eb0fd27f25aa90a3ad75d67a9f79f3f4f43
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NBL1 STAT4 PRDM1 SYNE2 GOLGA8A	1.32e-04	147	148	5	5e6dd2ddc67b3722f6528e7277cbc7f296098687
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	NPIPB15 IQCN AREG KMT2D ROM1	1.45e-04	150	148	5	744050a1b665c6989f37141348af3df7579a73c9
ToppCell	facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 DAB2 HPSE STAT4 MSR1	1.50e-04	151	148	5	3105b8c0c401faa92e1ab8223d435b21ed45c5b7
ToppCell	facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3BP2 LCP2 HPSE MSR1 AHRR	1.74e-04	156	148	5	3f0b9e35d4da85c90759b930052e5b9c3cde9b15
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	CTC1 STAT4 SYNE2 MACF1 GOLGA8A	1.74e-04	156	148	5	1545169694f686d28648a68b552c2ae606599d66
ToppCell	facs-Lung-nan-3m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3BP2 LCP2 HPSE MSR1 AHRR	1.74e-04	156	148	5	69e6e8810d1738a66c9821910f41498931cf30cc
ToppCell	droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLF8 NCAPH CENPI PAK1 GOLGA8A	1.96e-04	160	148	5	8a7a73b0ee1877fe02d47f745d36ae2858b529e1
ToppCell	BL-critical-LOC-Myeloid-Basophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RHOBTB3 AREG BRICD5 DNAH8 ATP6V0A2	2.08e-04	162	148	5	25ec9df914445b4daae4fd28fd0e60b64797c46d
ToppCell	Club_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	APOB PANX2 SCGB3A2 WNK2 EPHA10	2.20e-04	164	148	5	4e25e6362ef793b08de2f4d1dccb6b1fc9c072a5
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SCGB3A2 GOLGA8A FHIP1A WNK2 INO80B	2.26e-04	165	148	5	f6887c64af0f26e33316bc5587487e24d76ece2a
ToppCell	COVID-19_Mild-PLT_0\|COVID-19_Mild / Disease Group and Platelet Clusters	SATB2 HPSE MACF1 INO80B ARHGAP33	2.26e-04	165	148	5	083a14d3b0162cee4e79f7398b8fb739582b39ff
ToppCell	facs-GAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHISA5 LCP2 AREG STAT4 CISH	2.33e-04	166	148	5	d22a08b415ef9e48398d69f3e45b04c33a085411
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP3K4 PRDM1 SYNE2 GOLGA8A WNK2	2.39e-04	167	148	5	83969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCell	Control-T_cells-Tregs\|Control / group, cell type (main and fine annotations)	LCP2 STAT4 RESF1 SYNE2 DNAH8	2.53e-04	169	148	5	e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMA5 SCGB3A2 MRPS25 SYNE2 FHIP1A	2.60e-04	170	148	5	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	Control-Epithelial_cells-Airway_basal\|Control / group, cell type (main and fine annotations)	SHISA5 GLI3 KEL GOLGA8A WNK2	2.67e-04	171	148	5	3965ced4be6db14265a90673502fceee425837ca
ToppCell	normal-na-Lymphocytic_T-T4_em-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PRDM1 RESF1 PRRC2C SYNE2 MACF1	2.67e-04	171	148	5	61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LCP2 PRDM1 RESF1 SYNE2 GOLGA8A	2.67e-04	171	148	5	e6dfbd2652b67577c8834c05348f62150637f348
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LCP2 PRDM1 RESF1 SYNE2 GOLGA8A	2.67e-04	171	148	5	ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 RESF1 SYNE2 KMT2A MACF1	4.22e-05	49	86	5	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Drug	sulindac sulfide; Down 200; 50uM; MCF7; HG-U133A	IL11 MYO9B SH3BP2 APOB STAT4 PBRM1 RESF1 KMT2A AFF1 INO80B MAN1B1	5.67e-08	197	145	11	308_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	MYO9B SH3BP2 BCORL1 CIC NCOR1 SUPT6H MED25 PRRC2A INO80B PRRC2B	4.64e-07	193	145	10	3262_UP
Drug	novobiocin sodium, USP; Down 200; 100uM; SKMEL5; HG-U133A	COPA NCAPH MAP3K4 PRR14 CIZ1 EIF4G3 PRRC2A MAN1B1 ARHGAP33 PRRC2B	5.11e-07	195	145	10	632_DN
Drug	(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SPAG4 SH3BP2 BCORL1 LAMA5 CIC CISH RPAP1 CENPI CABIN1	5.41e-06	199	145	9	3531_DN
Drug	rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A	IL11 U2SURP MDM1 CCDC57 MSR1 MED25 PRR14L CABIN1	3.54e-05	194	145	8	5932_DN
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A	USP34 SH3BP2 REST FUBP1 CENPI PRR14L EIF4G3 CABIN1	3.54e-05	194	145	8	3431_DN
Drug	Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A	MDM1 MAP3K4 SUPT6H GLI3 FAM222B SIPA1L1 PRRC2A MED12	3.67e-05	195	145	8	6234_DN
Drug	Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A	SPAG4 SH3BP2 CCDC57 SUPT6H FUBP1 SIPA1L1 PAK1 AFF1	3.67e-05	195	145	8	2727_DN
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; HL60; HG-U133A	PPRC1 SH3BP2 NDUFB6 PRR14 FAM222B CIZ1 MACF1 ATP2A2	3.81e-05	196	145	8	1775_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	SPAG4 SH3BP2 CIC SUPT6H GLI3 CIZ1 INO80B PRRC2B	3.81e-05	196	145	8	4826_DN
Drug	Sulfachloropyridazine [80-32-0]; Up 200; 14uM; HL60; HT_HG-U133A	IL11 DAB2 PODXL2 CCDC57 GLI3 SIPA1L1 CIZ1 KEL	3.95e-05	197	145	8	2191_UP
Drug	Sulfanilamide [63-74-1]; Down 200; 23.2uM; HL60; HT_HG-U133A	SH3BP2 CCDC57 FUBP1 PAK1 KMT2A MACF1 ATP2A2 INO80B	3.95e-05	197	145	8	2709_DN
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A	MYO9B SH3BP2 REST CIC FAM222B ATP2A2 PRRC2A PRRC2B	3.95e-05	197	145	8	3411_DN
Drug	5155877; Down 200; 10uM; MCF7; HT_HG-U133A	NPL SLC12A6 USP34 CTC1 RHOBTB3 SH3BP2 ASAP1 INO80B	3.95e-05	197	145	8	6549_DN
Drug	Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A	CTC1 SLC12A5 RPAP1 GPATCH3 SUPT6H MARF1 KMT2A MED12	3.95e-05	197	145	8	3456_DN
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; HL60; HG-U133A	PPRC1 BCORL1 MAP3K4 AFF1 MACF1 CABIN1 PRRC2A PRRC2B	3.95e-05	197	145	8	2034_DN
Drug	IRFI005	APOB KEL	4.03e-05	2	145	2	CID000132223
Drug	Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A	USP34 SPAG4 SH3BP2 STAT2 PRDM1 GPATCH3 MED25 ARHGAP33	4.09e-05	198	145	8	1516_UP
Drug	Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A	SH3BP2 BCORL1 PODXL2 CISH GPATCH3 ROM1 ARHGAP33 PRRC2B	4.09e-05	198	145	8	6104_DN
Drug	Piracetam [7491-74-9]; Up 200; 28.2uM; HL60; HG-U133A	USP34 BCORL1 SEC31B NCAPH GPATCH3 FAM222B INO80B PRRC2B	4.09e-05	198	145	8	1710_UP
Drug	Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A	IL11 USP34 DAB2 APOB ZNF362 KMT2D SUPT6H MED25	4.24e-05	199	145	8	3615_UP
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A	NPL USP34 MDM1 PODXL2 ASAP1 RPAP1 GLI3 CABIN1	4.24e-05	199	145	8	5575_DN
Drug	Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A	U2SURP REST PRRC2C GLI3 PRR14L CABIN1 PRRC2A INO80B	4.39e-05	200	145	8	3438_DN
Disease	Malignant neoplasm of breast	TRERF1 BCORL1 TACC2 PANX2 HPSE CIC AREG STAT4 NCOR1 KMT2D PBRM1 SCGB3A2 SIPA1L1 SYNE2 ITSN2 PAK1 AFF1 MACF1 SPOCD1 PRRC2A MED12	4.39e-08	1074	141	21	C0006142
Disease	Wrinkly skin syndrome	KMT2A ATP6V0A2	2.27e-05	2	141	2	C0406587
Disease	Sjogren's Syndrome	STAT4 PRDM1 ITSN2	2.95e-05	13	141	3	C1527336
Disease	Sicca Syndrome	STAT4 PRDM1 ITSN2	2.95e-05	13	141	3	C0086981
Disease	testosterone measurement	KLF8 SATB2 MYO9B BCORL1 UBAP1 IQCN MIDEAS AREG MSR1 ZIC5 SYNE2 AFF1 MACF1 SPOCD1 USH2A MED12 RAI1 IGSF23	3.90e-05	1275	141	18	EFO_0004908
Disease	Craniofacial Abnormalities	SATB2 PRKRA SH3PXD2B ZIC5 RAI1 FOXI1	1.08e-04	156	141	6	C0376634
Disease	alpha fetoprotein measurement	USP34 NCOR1 ANKRD17 UNK AFF1	1.21e-04	100	141	5	EFO_0010583
Disease	non-high density lipoprotein cholesterol measurement	USP34 ADNP2 APOB MIDEAS AREG PRDM1 PBRM1 USO1 SYNE2 ITSN2 AFF1 RAI1	1.69e-04	713	141	12	EFO_0005689
Disease	Malignant Cystosarcoma Phyllodes	KMT2D MED12	2.25e-04	5	141	2	C0600066
Disease	Phyllodes Tumor	KMT2D MED12	2.25e-04	5	141	2	C0010701
Disease	level of Sterol ester (27:1/18:2) in blood serum	APOB AREG ANKRD17	2.56e-04	26	141	3	OBA_2045194
Disease	Bilateral Wilms Tumor	BCORL1 REST MAP3K4	3.56e-04	29	141	3	C2930471
Disease	level of Sphingomyelin (d38:1) in blood serum	AREG SYNE2 ANKRD17	3.95e-04	30	141	3	OBA_2045180
Disease	reticulocyte measurement	USP34 MYO9B RHOBTB3 U2SURP UBAP1 REST MIDEAS AREG USP10 SYNE2 EIF4G1 KEL SPOCD1 MED12	5.39e-04	1053	141	14	EFO_0010700
Disease	tyrosine-protein kinase receptor TYRO3 measurement	RPAP1 MGA	6.23e-04	8	141	2	EFO_0020829
Disease	Nephroblastoma	BCORL1 REST MAP3K4	6.79e-04	36	141	3	C0027708
Disease	Prostatic Neoplasms	MSR1 NCOR1 KMT2D USO1 ITSN2 CIZ1 KMT2A EIF3H MGA MED12	7.83e-04	616	141	10	C0033578
Disease	Malignant neoplasm of prostate	MSR1 NCOR1 KMT2D USO1 ITSN2 CIZ1 KMT2A EIF3H MGA MED12	7.83e-04	616	141	10	C0376358
Disease	triglycerides in large LDL measurement	APOB SYNE2 AFF1	1.15e-03	43	141	3	EFO_0022319
Disease	Breast Carcinoma	TRERF1 HPSE AREG NCOR1 KMT2D PBRM1 ITSN2 PAK1 MED12	1.16e-03	538	141	9	C0678222
Disease	schizophrenia, gastroesophageal reflux disease	SATB2 ATP2A2	1.21e-03	11	141	2	EFO_0003948, MONDO_0005090
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	APOB SYNE2 AFF1 MACF1	1.53e-03	103	141	4	EFO_0008595, EFO_0020944
Disease	reticulocyte count	USP34 MYO9B RHOBTB3 U2SURP REST MIDEAS AREG SLC12A5 USP10 SYNE2 KEL SPOCD1 MED12	1.55e-03	1045	141	13	EFO_0007986
Disease	apolipoprotein B to apolipoprotein A1 ratio	APOB DOCK6 IGSF23	1.68e-03	49	141	3	EFO_0021897
Disease	disease recurrence, colon carcinoma	MAP3K4 ZNF746 MACF1	1.88e-03	51	141	3	EFO_0004952, EFO_1001950
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	APOB ANKRD17	1.99e-03	14	141	2	EFO_0004611, EFO_0008589
Disease	cortical surface area measurement	USP34 SATB2 MYO9B NBL1 REST STOX1 NCOR1 PRRC2C GLI3 UNC5C AFF1 MACF1 PRRC2A WNK2 MOV10	1.99e-03	1345	141	15	EFO_0010736
Disease	obsolete_red blood cell distribution width	MYO9B SHISA5 U2SURP UBAP1 APOB REST MIDEAS AHRR PBRM1 RESF1 PRRC2C FAM222B SYNE2 EIF4G3 DOCK6	2.02e-03	1347	141	15	EFO_0005192
Disease	lipoprotein A measurement	APOB MAP3K4 TULP4 AFF1	2.08e-03	112	141	4	EFO_0006925
Disease	diffuse idiopathic skeletal hyperostosis	IL11 ROR2	2.29e-03	15	141	2	EFO_0007236
Disease	vital capacity	IL11 USP34 NBL1 VTA1 APOB NCOR1 TULP4 GLI3 AFF1 SMARCD2 ROM1 EIF3H ATP2A2 MOV10	2.45e-03	1236	141	14	EFO_0004312
Disease	triglycerides in LDL measurement	APOB SYNE2 AFF1	2.46e-03	56	141	3	EFO_0022320
Disease	T-Cell Lymphoma	KMT2D MGA	2.60e-03	16	141	2	C0079772
Disease	level of Sterol ester (27:1/18:1) in blood serum	AREG ANKRD17	2.60e-03	16	141	2	OBA_2045195
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	APOB SYNE2 AFF1 MACF1	2.76e-03	121	141	4	EFO_0008595, EFO_0020943
Disease	Dystonia, Limb	PRKRA CIZ1	2.94e-03	17	141	2	C0751093
Disease	Dystonia, Diurnal	PRKRA CIZ1	2.94e-03	17	141	2	C0393610
Disease	serum alanine aminotransferase measurement	BCORL1 LAMA5 APOB IQCN RESF1 PRPF3 FAM222B MARF1 UNK SMARCD2 WNK2	3.11e-03	869	141	11	EFO_0004735
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	APOB SYNE2 AFF1 MACF1	3.28e-03	127	141	4	EFO_0008595, EFO_0020947
Disease	Dystonia, Paroxysmal	PRKRA CIZ1	3.30e-03	18	141	2	C0393588
Disease	level of Sphingomyelin (d34:1) in blood serum	AREG ANKRD17	3.30e-03	18	141	2	OBA_2045175
Disease	Myeloid Leukemia	KMT2A SMARCD2	3.30e-03	18	141	2	C0023470
Disease	Leukemia, Monocytic, Chronic	KMT2A SMARCD2	3.30e-03	18	141	2	C0023466
Disease	Sarcomatoid Renal Cell Carcinoma	PBRM1 SYNE2 UNC5C PAK1	3.37e-03	128	141	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	PBRM1 SYNE2 UNC5C PAK1	3.37e-03	128	141	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	PBRM1 SYNE2 UNC5C PAK1	3.37e-03	128	141	4	C1266044
Disease	Papillary Renal Cell Carcinoma	PBRM1 SYNE2 UNC5C PAK1	3.37e-03	128	141	4	C1306837
Disease	Renal Cell Carcinoma	PBRM1 SYNE2 UNC5C PAK1	3.37e-03	128	141	4	C0007134
Disease	Schizophrenia	MYO9B ADNP2 REST GFRA3 SLC12A5 PBRM1 UNC5C KMT2A ATP2A2 MED12 RAI1	3.51e-03	883	141	11	C0036341
Disease	level of Sphingomyelin (d38:2) in blood serum	AREG ANKRD17	3.68e-03	19	141	2	OBA_2045179
Disease	Mammary Carcinoma, Human	TRERF1 HPSE AREG NCOR1 KMT2D ITSN2 PAK1 MED12	3.84e-03	525	141	8	C4704874
Disease	Mammary Neoplasms, Human	TRERF1 HPSE AREG NCOR1 KMT2D ITSN2 PAK1 MED12	3.84e-03	525	141	8	C1257931
Disease	Mammary Neoplasms	TRERF1 HPSE AREG NCOR1 KMT2D ITSN2 PAK1 MED12	3.93e-03	527	141	8	C1458155
Disease	Precursor B-cell lymphoblastic leukemia	KMT2A AFF1	4.49e-03	21	141	2	C1292769
Disease	transferrin glycosylation measurement	MSR1 FOXI1	4.49e-03	21	141	2	EFO_0021537
Disease	Profound Mental Retardation	CIC PRKRA MAN1B1 RAI1	4.52e-03	139	141	4	C0020796
Disease	Mental Retardation, Psychosocial	CIC PRKRA MAN1B1 RAI1	4.52e-03	139	141	4	C0025363
Disease	Mental deficiency	CIC PRKRA MAN1B1 RAI1	4.52e-03	139	141	4	C0917816
Disease	chemokine (C-C motif) ligand 27 measurement	UBAP1 NDUFB6 PBRM1	4.63e-03	70	141	3	EFO_0008082
Disease	Bladder Neoplasm	ASAP1 NCOR1 KMT2D KMT2A	4.64e-03	140	141	4	C0005695
Disease	Malignant neoplasm of urinary bladder	ASAP1 NCOR1 KMT2D KMT2A	4.76e-03	141	141	4	C0005684

Protein segments in the cluster

Peptide	Gene	Start	Entry
RQPPIMQPPLDLKQI	ZNF385A	16	Q96PM9
MQPPLDLKQILPFPL	ZNF385A	21	Q96PM9
QPSKNDPPSLRPMPR	AHRR	421	A9YTQ3
AQFMPNPLLPAPILV	BDP1	2306	A6H8Y1
KPAIPTPLEVQMAQP	CFAP61	1056	Q8NHU2
KPPQPPARMDSLLIA	EIF3H	306	O15372
MRAPLLPPAPVVLSL	AREG	1	P15514
LQKQQAPRMDTPPPE	CCDC89	6	Q8N998
TLQRQVRIPQMPAPP	ADAMTSL4	641	Q6UY14
LLEADPKPLPMPSNS	CTC1	326	Q2NKJ3
ALPPIKENMPKNVLP	BRDT	241	Q58F21
QGPPKPRLQTLRMTL	BRICD5	56	Q6PL45
PALKLPVPEAMARPA	SH3BP2	386	P78314
MARPAVLPRPEKPQL	SH3BP2	396	P78314
LKSPPQLEREMASPP	BCORL1	601	Q5H9F3
VLATPQNLPKMPELP	BCORL1	996	Q5H9F3
QNLPKMPELPLLPHD	BCORL1	1001	Q5H9F3
SLELPKPVMQPLPAG	CISH	26	Q9NSE2
INLLPLPDPIPSGLM	DDX20	431	Q9UHI6
APIQPLAMPQALPLA	ANKRD17	951	O75179
LPKEINLTPKPNRMP	C6orf201	46	Q7Z4U5
LSRQMVPQLQLPEPP	EFCAB12	171	Q6NXP0
LATVAPPQMPIQLLP	ADNP2	631	Q6IQ32
PEQRPGMQDPLSPKA	RAI1	881	Q7Z5J4
MAKAGQPLPLTLPPE	ITSN2	311	Q9NZM3
PSLLDKMEKAPPQPQ	IQCN	41	Q9H0B3
AQELPNLPSPLPKMN	PODXL2	136	Q9NZ53
QLLNKINEPPKPAPR	DAB2	706	P98082
MPPDLLLQVLKPLDP	FAM47C	141	Q5HY64
PAQKELLPPVEPAQM	REST	661	Q13127
TPMFVAPPPKTQRLL	PBRM1	1591	Q86U86
VNGMFPRLNPILPPK	GLI3	786	P10071
EPMKPLLLPQPEVLS	MGA	1181	Q8IWI9
LEPLPLQMPSLPNSQ	ITPRID1	431	Q6ZRS4
PPPNADPNMKLFTIR	FUBP1	416	Q96AE4
TGPPPVNKPEMRLLC	FAM90A27P	166	A6NNH2
LPELNPPVLMPRGNV	GPATCH3	181	Q96I76
QLLMSRLALPQPPPD	IL11	141	P20809
QELSPREPVLPPQKM	NDUFB6	26	O95139
TPNPMALALPSPALK	FAM205A	391	Q6ZU69
TPNPMALALPSPALK	FAM205BP	121	Q63HN1
ARLLPEAIMNPPVAP	FAM222B	121	Q8WU58
QKDDPPLARNMPPIA	DNAH8	501	Q96JB1
LVSPSKMKPPAPEQR	MDM1	541	Q8TC05
APLQPASMLQAPIRP	KLF8	96	O95600
ASMLQAPIRPPKPQS	KLF8	101	O95600
PPMPILSQSEAKNPR	MACF1	3101	O94854
TPVPLFPNENLPSKM	LARP6	171	Q9BRS8
DPYRPVRLPMQKLPT	MED12	1856	Q93074
AQLPPRAPLPGQMLL	MED25	706	Q71SY5
PPPRNCPNLLHRLML	EPHA10	866	Q5JZY3
LQQMKPHRGPPPELQ	LAMA5	3221	O15230
AETLKNRMGRQPPPP	NPIPB7	236	O75200
LPAMLLAAPPPINKL	NBL1	11	P41271
AEALKNRMGRQPPPP	NPIPB15	236	A6NHN6
QTLPPLMEKPLRPGS	HPSE	506	Q9Y251
MRPEIAGLKPANPPV	MAN1B1	121	Q9UKM7
KARSQPSPMLPLPVA	INO80B	186	Q9C086
RSMTALLPPNPKNSP	MSR1	26	P21757
LDIQDKPPAPPMRNT	PAK1	6	Q13153
PPPKNPARLMALALA	ARHGAP33	891	O14559
MDPPRPALLALLALP	APOB	1	P04114
MNKPPRNPKEPLISG	ATP2A2	816	P16615
EAPPNLPLPVRNPML	FHIP1A	991	Q05DH4
FPPLNPMLPSIISKD	IGSF10	1291	Q6WRI0
MRAKPQSPLPRNPVP	IGSF23	1	A1L1A6
SRPLPNMPKLVIPSA	CABIN1	2126	Q9Y6J0
PLLTQRLPQLMAPTP	DOCK6	2016	Q96HP0
NPRPLPPVVLMLLLL	GFRA3	6	O60609
NTRPPMPILEQKLEP	COL20A1	1216	Q9P218
NAKLLQPPAPIMPLD	COPA	791	P53621
PLPLPQIEKPSQEMV	AWAT1	281	Q58HT5
LSAMPPAPEDLKPQQ	CC2D1B	331	Q5T0F9
LPAPPAADRRPVKMQ	CCDC57	856	Q2TAC2
QLSDLPPKPQMKDLP	ASAP1	976	Q9ULH1
TPVLMNQPPQIAPKR	EIF4G1	161	Q04637
ISDLPPRLPLKMPQC	MARF1	496	Q9Y4F3
FPPNPDMNPELRKAL	MIDEAS	311	Q6PJG2
LPVQDRNLMLPDGPK	KMT2A	2591	Q03164
PIPSQEELMKLVRPP	FOXI1	111	Q12951
EPLKLMLGPANVRPL	CENPI	286	Q92674
NPPMRQKRAVFPPLV	ERVFC1	376	P60507
AKLVLLNMPGPPRNP	SLC12A6	1101	Q9UHW9
VMPPEQPLPVKCNRI	INPP5F	486	Q9Y2H2
INQPKLPMRTLDPRI	EIF4G3	656	O43432
QVPSQEMPLLARPSP	PPRC1	846	Q5VV67
AETLKNRMGRQPPPP	NPIPB9	251	F8W1W9
LGLMPPPEPKVRISN	PRPF3	466	O43395
RKTIPRPDPNLTPMG	PRR14L	2016	Q5THK1
SNPLPQPFKEPLAIM	PANX2	436	Q96RD6
PPQLEQPEKMPVLKA	RHOBTB3	221	O94955
KLVLLNMPGPPRNRN	SLC12A5	1091	Q9H2X9
AKLPVSVPMPIARPA	MAP3K4	196	Q9Y6R4
RLKNQMAEPLPPDAP	GOLGA8A	306	A7E2F4
IPMGPPRLPLQKASR	NPL	276	Q9BXD5
QVPCPSLVPLPKEMR	MRPS25	146	P82663
MLVSPAPVPLPLLAQ	TAF3	806	Q5VWG9
APPQRLSPPKMQKIS	USH2A	1241	O75445
RPPLVPLQKRMSPLN	USH2A	5076	O75445
APSNPPRPAIVVLLM	USO1	356	O60763
PLPLDNILPFMDPLK	SCGB3A2	36	Q96PL1
RGQPIPKRMLPPEEL	MRPL15	196	Q9P015
QPCMPQTPHRPLILK	STAT2	321	P52630
QVELRLPQTGMKPLP	SYNE2	3951	Q8WXH0
PPPRLRQLLPMLLQG	MOV10	296	Q9HCE1
LPLKMVEPQKPSLPN	RESF1	916	Q9HCM1
ERNMLPSTPLKPPVP	SEC24A	356	O95486
PLDPTAQLRIMPLPA	NCOR1	1786	O75376
TPARPQLNLTPMGLP	PRR14	451	Q9BWN1
SRRMPPPANLPSLKA	PRRC2C	51	Q9Y520
MPPPANLPSLKAENK	PRRC2A	56	P48634
PIRNQVPALQPIMSP	SATB2	281	Q9UPW6
KMPPPERAANIPRSI	SIPA1L1	1101	O43166
MTAPVPAPRILLPLL	SHISA5	1	Q8N114
PPPQMPVLAALRDLS	MRGPRG-AS1	56	Q2M3A8
DLPLMKLPPSNPLPL	PRDM1	796	O75626
LQLPKCEALPMPESP	ROR2	281	Q01974
RNKLPETFMPPAPIT	SEC31B	1006	Q9NQW1
QPSANKPKPPTMLDI	SUPT7L	41	O94864
LLPTLDLRQEMPPPR	SPAG4	116	Q9NPE6
PKLELMPLETPQALP	TRPT1	111	Q86TN4
RKRLLVPQAQPPMPA	SMARCD2	116	Q92925
QPRERLKNPNAPMLP	U2SURP	386	O15042
PLRDTPPPQSLMVKI	AFF1	751	P51825
MSPEIQLPLPPGKRR	CIC	156	Q96RK0
PMGSEPVPKSRINLP	SLC25A13	616	Q9UJS0
ERVFPMPLPRKAPLN	NCAPH	31	Q15003
LLQQSPPQAPLPMAV	CIZ1	41	Q9ULV3
KQKQRLTPRPSPSPM	SUPT6H	1691	Q7KZ85
RFCVPPVLPPKLTMN	WFDC3	201	Q8IUB2
IKPPIPDPNNMRDFV	TULP4	416	Q9NRJ4
ATMPPPINPILASLQ	UBAP1	111	Q9NZ09
MAPVLPLVLPLQPRI	ROM1	1	Q03395
MAALAPLPPLPAQFK	VTA1	1	Q9NP79
PATQPIPRIKSPNEM	STOX1	456	Q6ZVD7
DMTIPRGLNLPKPPI	SH3PXD2B	351	A1X283
QPCMPTHPQRPLVLK	STAT4	321	Q14765
MVLLPLPAFQPLPTR	SPOCD1	966	Q6ZMY3
MRPHLSPPLQQLLLP	SCTR	1	P47872
MPNLVPPKIPDGERV	TNNT2	81	P45379
RMPPPANLPSLKSEN	PRRC2B	56	Q5JSZ5
LKPMAPIPQDPAPRA	TACC2	271	O95359
LQRVPTLLLPMPTEP	RPAP1	1081	Q9BWH6
DPLMPDPSKQPKNQL	PRKRA	111	O75569
EQLMAEKIRPPHLPP	ZNF362	46	Q5T0B9
EFTNMPVPPKPRQAL	USP10	471	Q14694
GPPVPAPDLLMQIKQ	ZNF746	176	Q6NUN9
LPPPQKDNIPMLLLL	USP34	1331	Q70CQ2
APAQLKPLQMPQAPL	WNK2	771	Q9Y3S1
PLLQPKQDMLGILPA	UNK	451	Q9C0B0
DKIPMTNSPILDPLP	UNC5C	461	O95185
PPAPPLKQVLEMQEQ	ATP6V0A2	86	Q9Y487
CVVLMEPPLSKRNPP	ZIC5	21	Q96T25
LRQLLSQKPMEPPAP	TRERF1	181	Q96PN7
KLRELTEQPPMPARP	KEL	391	P23276
LMEPLPPQCSPLLQH	KMT2D	1016	O14686
QRPLPQPALLPMSSN	LCP2	326	Q13094
RTPIMPTANIKLPPG	MYO9B	2061	Q13459